id	sid	tid	token	lemma	pos
biomedich-767	1	1	biology	biology	NOUN
biomedich-767	1	2	,	,	PUNCT
biomedich-767	1	3	medicine	medicine	NOUN
biomedich-767	1	4	,	,	PUNCT
biomedich-767	1	5	&	&	CCONJ
biomedich-767	1	6	natural	natural	ADJ
biomedich-767	1	7	product	product	NOUN
biomedich-767	1	8	chemistry	chemistry	NOUN
biomedich-767	1	9	issn	issn	VERB
biomedich-767	1	10	2089	2089	NUM
biomedich-767	1	11	-	-	SYM
biomedich-767	1	12	6514	6514	NUM
biomedich-767	1	13	(	(	PUNCT
biomedich-767	1	14	paper	paper	NOUN
biomedich-767	1	15	)	)	PUNCT
biomedich-767	1	16	volume	volume	NOUN
biomedich-767	1	17	14	14	NUM
biomedich-767	1	18	,	,	PUNCT
biomedich-767	1	19	number	number	NOUN
biomedich-767	1	20	2	2	NUM
biomedich-767	1	21	,	,	PUNCT
biomedich-767	1	22	october	october	PROPN
biomedich-767	1	23	2025	2025	NUM
biomedich-767	1	24	|	|	ADV
biomedich-767	1	25	pages	page	NOUN
biomedich-767	1	26	:	:	PUNCT
biomedich-767	1	27	1219	1219	NUM
biomedich-767	1	28	-	-	SYM
biomedich-767	1	29	1223	1223	NUM
biomedich-767	1	30	|	|	ADV
biomedich-767	1	31	doi	doi	NOUN
biomedich-767	1	32	:	:	PUNCT
biomedich-767	1	33	10.14421	10.14421	NUM
biomedich-767	1	34	/	/	SYM
biomedich-767	1	35	biomedich.2025.142.1219	biomedich.2025.142.1219	NOUN
biomedich-767	1	36	-	-	PUNCT
biomedich-767	1	37	1223	1223	NUM
biomedich-767	1	38	issn	issn	PROPN
biomedich-767	1	39	2540	2540	NUM
biomedich-767	1	40	-	-	SYM
biomedich-767	1	41	9328	9328	NUM
biomedich-767	1	42	(	(	PUNCT
biomedich-767	1	43	online	online	ADJ
biomedich-767	1	44	)	)	PUNCT
biomedich-767	1	45	cost	cost	NOUN
biomedich-767	1	46	effectiveness	effectiveness	NOUN
biomedich-767	1	47	analysis	analysis	NOUN
biomedich-767	1	48	of	of	ADP
biomedich-767	1	49	favipiravir	favipiravir	NOUN
biomedich-767	1	50	and	and	CCONJ
biomedich-767	1	51	oseltamivir	oseltamivir	NOUN
biomedich-767	1	52	as	as	ADP
biomedich-767	1	53	antiretroviral	antiretroviral	ADJ
biomedich-767	1	54	covid-19	covid-19	PROPN
biomedich-767	1	55	of	of	ADP
biomedich-767	1	56	patients	patient	NOUN
biomedich-767	1	57	in	in	ADP
biomedich-767	1	58	bogor	bogor	PROPN
biomedich-767	1	59	cisarua	cisarua	PROPN
biomedich-767	1	60	lung	lung	PROPN
biomedich-767	1	61	hospital	hospital	PROPN
biomedich-767	1	62	ani	ani	X
biomedich-767	2	1	rahayu1	rahayu1	PROPN
biomedich-767	2	2	,	,	PUNCT
biomedich-767	2	3	dwi	dwi	PROPN
biomedich-767	2	4	puspita	puspita	PROPN
biomedich-767	2	5	sari2	sari2	PROPN
biomedich-767	2	6	,	,	PUNCT
biomedich-767	2	7	lukluk	lukluk	PROPN
biomedich-767	2	8	utami	utami	NOUN
biomedich-767	2	9	ningsih3	ningsih3	PROPN
biomedich-767	2	10	,	,	PUNCT
biomedich-767	2	11	a.	a.	PROPN
biomedich-767	2	12	triwildan	triwildan	PROPN
biomedich-767	2	13	st	st	PROPN
biomedich-767	2	14	fatimah4	fatimah4	PROPN
biomedich-767	2	15	1,2pharmacy	1,2pharmacy	NUM
biomedich-767	2	16	study	study	NOUN
biomedich-767	2	17	program	program	NOUN
biomedich-767	2	18	at	at	ADP
biomedich-767	2	19	binawan	binawan	PROPN
biomedich-767	2	20	university	university	PROPN
biomedich-767	2	21	,	,	PUNCT
biomedich-767	2	22	jakarta	jakarta	PROPN
biomedich-767	2	23	,	,	PUNCT
biomedich-767	2	24	indonesia	indonesia	PROPN
biomedich-767	2	25	.	.	PUNCT
biomedich-767	3	1	3cisarua	3cisarua	NUM
biomedich-767	3	2	lung	lung	NOUN
biomedich-767	3	3	hospital	hospital	NOUN
biomedich-767	3	4	,	,	PUNCT
biomedich-767	3	5	bogor	bogor	PROPN
biomedich-767	3	6	,	,	PUNCT
biomedich-767	3	7	indonesia	indonesia	PROPN
biomedich-767	3	8	.	.	PUNCT
biomedich-767	4	1	4raden	4raden	NUM
biomedich-767	4	2	mattaher	mattaher	ADJ
biomedich-767	4	3	hospital	hospital	NOUN
biomedich-767	4	4	,	,	PUNCT
biomedich-767	4	5	jambi	jambi	PROPN
biomedich-767	4	6	,	,	PUNCT
biomedich-767	4	7	indonesia	indonesia	PROPN
biomedich-767	4	8	.	.	PUNCT
biomedich-767	5	1	corresponding	correspond	VERB
biomedich-767	5	2	author	author	NOUN
biomedich-767	5	3	*	*	PUNCT
biomedich-767	5	4	ani.rahayu@binawan.ac.id	ani.rahayu@binawan.ac.id	PROPN
biomedich-767	5	5	abstract	abstract	ADJ
biomedich-767	5	6	favipiravir	favipiravir	PROPN
biomedich-767	5	7	is	be	AUX
biomedich-767	5	8	a	a	DET
biomedich-767	5	9	type	type	NOUN
biomedich-767	5	10	of	of	ADP
biomedich-767	5	11	rna	rna	NOUN
biomedich-767	5	12	-	-	PUNCT
biomedich-767	5	13	dependent	dependent	ADJ
biomedich-767	5	14	rna	rna	NOUN
biomedich-767	5	15	polymerase	polymerase	NOUN
biomedich-767	5	16	(	(	PUNCT
biomedich-767	5	17	rdrp	rdrp	NOUN
biomedich-767	5	18	)	)	PUNCT
biomedich-767	5	19	inhibitor	inhibitor	NOUN
biomedich-767	5	20	.	.	PUNCT
biomedich-767	6	1	favipiravir	favipiravir	PROPN
biomedich-767	6	2	is	be	AUX
biomedich-767	6	3	converted	convert	VERB
biomedich-767	6	4	by	by	ADP
biomedich-767	6	5	host	host	NOUN
biomedich-767	6	6	enzymes	enzyme	NOUN
biomedich-767	6	7	to	to	ADP
biomedich-767	6	8	t-705ribofuranosyl	t-705ribofuranosyl	NOUN
biomedich-767	6	9	5′-triphosphate	5′-triphosphate	PROPN
biomedich-767	6	10	and	and	CCONJ
biomedich-767	6	11	may	may	AUX
biomedich-767	6	12	act	act	VERB
biomedich-767	6	13	as	as	ADP
biomedich-767	6	14	a	a	DET
biomedich-767	6	15	nucleotide	nucleotide	ADJ
biomedich-767	6	16	analogue	analogue	NOUN
biomedich-767	6	17	that	that	PRON
biomedich-767	6	18	selectively	selectively	ADV
biomedich-767	6	19	inhibits	inhibit	VERB
biomedich-767	6	20	viral	viral	ADJ
biomedich-767	6	21	rna	rna	NOUN
biomedich-767	6	22	-	-	PUNCT
biomedich-767	6	23	dependent	dependent	ADJ
biomedich-767	6	24	rna	rna	NOUN
biomedich-767	6	25	polymerase	polymerase	NOUN
biomedich-767	6	26	or	or	CCONJ
biomedich-767	6	27	causes	cause	VERB
biomedich-767	6	28	lethal	lethal	ADJ
biomedich-767	6	29	mutagenesis	mutagenesis	NOUN
biomedich-767	6	30	upon	upon	SCONJ
biomedich-767	6	31	insertion	insertion	NOUN
biomedich-767	6	32	into	into	ADP
biomedich-767	6	33	viral	viral	ADJ
biomedich-767	6	34	rna	rna	NOUN
biomedich-767	6	35	without	without	ADP
biomedich-767	6	36	cytotoxicity	cytotoxicity	NOUN
biomedich-767	6	37	in	in	ADP
biomedich-767	6	38	mammalian	mammalian	ADJ
biomedich-767	6	39	cells	cell	NOUN
biomedich-767	6	40	.	.	PUNCT
biomedich-767	7	1	oseltamivir	oseltamivir	PROPN
biomedich-767	7	2	is	be	AUX
biomedich-767	7	3	part	part	NOUN
biomedich-767	7	4	of	of	ADP
biomedich-767	7	5	the	the	DET
biomedich-767	7	6	neuraminidase	neuraminidase	NOUN
biomedich-767	7	7	inhibitors	inhibitor	NOUN
biomedich-767	7	8	(	(	PUNCT
biomedich-767	7	9	nais	nais	NOUN
biomedich-767	7	10	)	)	PUNCT
biomedich-767	7	11	group	group	NOUN
biomedich-767	7	12	which	which	PRON
biomedich-767	7	13	has	have	VERB
biomedich-767	7	14	a	a	DET
biomedich-767	7	15	mechanism	mechanism	NOUN
biomedich-767	7	16	of	of	ADP
biomedich-767	7	17	action	action	NOUN
biomedich-767	7	18	by	by	ADP
biomedich-767	7	19	inhibiting	inhibit	VERB
biomedich-767	7	20	viral	viral	ADJ
biomedich-767	7	21	neuraminidase	neuraminidase	NOUN
biomedich-767	7	22	.	.	PUNCT
biomedich-767	8	1	most	most	ADJ
biomedich-767	8	2	of	of	ADP
biomedich-767	8	3	the	the	DET
biomedich-767	8	4	alternative	alternative	ADJ
biomedich-767	8	5	therapies	therapy	NOUN
biomedich-767	8	6	for	for	ADP
biomedich-767	8	7	covid-19	covid-19	PROPN
biomedich-767	8	8	require	require	VERB
biomedich-767	8	9	pharmacoeconomic	pharmacoeconomic	ADJ
biomedich-767	8	10	studies	study	NOUN
biomedich-767	8	11	,	,	PUNCT
biomedich-767	8	12	especially	especially	ADV
biomedich-767	8	13	regarding	regard	VERB
biomedich-767	8	14	cost	cost	NOUN
biomedich-767	8	15	-	-	PUNCT
biomedich-767	8	16	effectiveness	effectiveness	NOUN
biomedich-767	8	17	analysis	analysis	NOUN
biomedich-767	8	18	which	which	PRON
biomedich-767	8	19	is	be	AUX
biomedich-767	8	20	useful	useful	ADJ
biomedich-767	8	21	in	in	ADP
biomedich-767	8	22	balancing	balance	VERB
biomedich-767	8	23	patient	patient	ADJ
biomedich-767	8	24	expenses	expense	NOUN
biomedich-767	8	25	by	by	ADP
biomedich-767	8	26	determining	determine	VERB
biomedich-767	8	27	treatment	treatment	NOUN
biomedich-767	8	28	alternatives	alternative	NOUN
biomedich-767	8	29	that	that	PRON
biomedich-767	8	30	represent	represent	VERB
biomedich-767	8	31	the	the	DET
biomedich-767	8	32	best	good	ADJ
biomedich-767	8	33	health	health	NOUN
biomedich-767	8	34	outcomes	outcome	NOUN
biomedich-767	8	35	at	at	ADP
biomedich-767	8	36	a	a	DET
biomedich-767	8	37	more	more	ADV
biomedich-767	8	38	affordable	affordable	ADJ
biomedich-767	8	39	cost	cost	NOUN
biomedich-767	8	40	.	.	PUNCT
biomedich-767	9	1	the	the	DET
biomedich-767	9	2	aim	aim	NOUN
biomedich-767	9	3	of	of	ADP
biomedich-767	9	4	this	this	DET
biomedich-767	9	5	study	study	NOUN
biomedich-767	9	6	was	be	AUX
biomedich-767	9	7	to	to	PART
biomedich-767	9	8	compare	compare	VERB
biomedich-767	9	9	the	the	DET
biomedich-767	9	10	cost	cost	NOUN
biomedich-767	9	11	effectiveness	effectiveness	NOUN
biomedich-767	9	12	of	of	ADP
biomedich-767	9	13	the	the	DET
biomedich-767	9	14	antiretrovirals	antiretroviral	NOUN
biomedich-767	9	15	favipiravir	favipiravir	NOUN
biomedich-767	9	16	and	and	CCONJ
biomedich-767	9	17	oseltamivir	oseltamivir	PROPN
biomedich-767	9	18	.	.	PUNCT
biomedich-767	10	1	this	this	DET
biomedich-767	10	2	research	research	NOUN
biomedich-767	10	3	method	method	NOUN
biomedich-767	10	4	used	use	VERB
biomedich-767	10	5	a	a	DET
biomedich-767	10	6	descriptive	descriptive	ADJ
biomedich-767	10	7	analytic	analytic	ADJ
biomedich-767	10	8	cross	cross	ADJ
biomedich-767	10	9	-	-	ADJ
biomedich-767	10	10	sectional	sectional	ADJ
biomedich-767	10	11	design	design	NOUN
biomedich-767	10	12	and	and	CCONJ
biomedich-767	10	13	data	datum	NOUN
biomedich-767	10	14	collection	collection	NOUN
biomedich-767	10	15	was	be	AUX
biomedich-767	10	16	carried	carry	VERB
biomedich-767	10	17	out	out	ADP
biomedich-767	10	18	retrospectively	retrospectively	ADV
biomedich-767	10	19	from	from	ADP
biomedich-767	10	20	the	the	DET
biomedich-767	10	21	medical	medical	ADJ
biomedich-767	10	22	records	record	NOUN
biomedich-767	10	23	of	of	ADP
biomedich-767	10	24	covid-19	covid-19	PROPN
biomedich-767	10	25	sufferers	sufferer	NOUN
biomedich-767	10	26	while	while	SCONJ
biomedich-767	10	27	detailed	detailed	ADJ
biomedich-767	10	28	data	datum	NOUN
biomedich-767	10	29	on	on	ADP
biomedich-767	10	30	medical	medical	ADJ
biomedich-767	10	31	expenses	expense	NOUN
biomedich-767	10	32	were	be	AUX
biomedich-767	10	33	obtained	obtain	VERB
biomedich-767	10	34	from	from	ADP
biomedich-767	10	35	the	the	DET
biomedich-767	10	36	finance	finance	NOUN
biomedich-767	10	37	department	department	NOUN
biomedich-767	10	38	of	of	ADP
biomedich-767	10	39	inpatients	inpatient	NOUN
biomedich-767	10	40	at	at	ADP
biomedich-767	10	41	cisarua	cisarua	PROPN
biomedich-767	10	42	pulmonary	pulmonary	PROPN
biomedich-767	10	43	hospital	hospital	NOUN
biomedich-767	10	44	,	,	PUNCT
biomedich-767	10	45	bogor	bogor	NOUN
biomedich-767	10	46	for	for	ADP
biomedich-767	10	47	the	the	DET
biomedich-767	10	48	period	period	NOUN
biomedich-767	10	49	september	september	PROPN
biomedich-767	10	50	-	-	PUNCT
biomedich-767	10	51	october	october	PROPN
biomedich-767	10	52	2022	2022	NUM
biomedich-767	10	53	.	.	PUNCT
biomedich-767	11	1	sample	sample	NOUN
biomedich-767	11	2	of	of	ADP
biomedich-767	11	3	80	80	NUM
biomedich-767	11	4	patients	patient	NOUN
biomedich-767	11	5	consisted	consist	VERB
biomedich-767	11	6	of	of	ADP
biomedich-767	11	7	40	40	NUM
biomedich-767	11	8	patients	patient	NOUN
biomedich-767	11	9	using	use	VERB
biomedich-767	11	10	favipiravir	favipiravir	NOUN
biomedich-767	11	11	and	and	CCONJ
biomedich-767	11	12	40	40	NUM
biomedich-767	11	13	patients	patient	NOUN
biomedich-767	11	14	using	use	VERB
biomedich-767	11	15	oseltamivir.the	oseltamivir.the	DET
biomedich-767	11	16	parameters	parameter	NOUN
biomedich-767	11	17	used	use	VERB
biomedich-767	11	18	in	in	ADP
biomedich-767	11	19	this	this	DET
biomedich-767	11	20	research	research	NOUN
biomedich-767	11	21	are	be	AUX
biomedich-767	11	22	direct	direct	ADJ
biomedich-767	11	23	medical	medical	ADJ
biomedich-767	11	24	costs	cost	NOUN
biomedich-767	11	25	(	(	PUNCT
biomedich-767	11	26	which	which	PRON
biomedich-767	11	27	include	include	VERB
biomedich-767	11	28	doctor	doctor	NOUN
biomedich-767	11	29	visit	visit	NOUN
biomedich-767	11	30	costs	cost	NOUN
biomedich-767	11	31	,	,	PUNCT
biomedich-767	11	32	treatment	treatment	NOUN
biomedich-767	11	33	room	room	NOUN
biomedich-767	11	34	costs	cost	NOUN
biomedich-767	11	35	,	,	PUNCT
biomedich-767	11	36	laboratory	laboratory	NOUN
biomedich-767	11	37	costs	cost	NOUN
biomedich-767	11	38	and	and	CCONJ
biomedich-767	11	39	drug	drug	NOUN
biomedich-767	11	40	costs	cost	NOUN
biomedich-767	11	41	)	)	PUNCT
biomedich-767	11	42	while	while	SCONJ
biomedich-767	11	43	the	the	DET
biomedich-767	11	44	effectiveness	effectiveness	NOUN
biomedich-767	11	45	uses	use	VERB
biomedich-767	11	46	a	a	DET
biomedich-767	11	47	negative	negative	ADJ
biomedich-767	11	48	rt	rt	ADJ
biomedich-767	11	49	pcr	pcr	ADJ
biomedich-767	11	50	value	value	NOUN
biomedich-767	11	51	.	.	PUNCT
biomedich-767	12	1	the	the	DET
biomedich-767	12	2	results	result	NOUN
biomedich-767	12	3	showed	show	VERB
biomedich-767	12	4	that	that	SCONJ
biomedich-767	12	5	in	in	ADP
biomedich-767	12	6	patients	patient	NOUN
biomedich-767	12	7	using	use	VERB
biomedich-767	12	8	favipiravir	favipiravir	NOUN
biomedich-767	12	9	with	with	ADP
biomedich-767	12	10	an	an	DET
biomedich-767	12	11	average	average	ADJ
biomedich-767	12	12	length	length	NOUN
biomedich-767	12	13	of	of	ADP
biomedich-767	12	14	treatment	treatment	NOUN
biomedich-767	12	15	6.525	6.525	NUM
biomedich-767	12	16	days	day	NOUN
biomedich-767	12	17	,	,	PUNCT
biomedich-767	12	18	the	the	DET
biomedich-767	12	19	total	total	ADJ
biomedich-767	12	20	cost	cost	NOUN
biomedich-767	12	21	was	be	AUX
biomedich-767	12	22	rp	rp	NOUN
biomedich-767	12	23	.	.	PUNCT
biomedich-767	13	1	9,930,327	9,930,327	NUM
biomedich-767	13	2	/	/	SYM
biomedich-767	13	3	patient	patient	ADJ
biomedich-767	13	4	and	and	CCONJ
biomedich-767	13	5	cost	cost	NOUN
biomedich-767	13	6	-	-	PUNCT
biomedich-767	13	7	effectiveness	effectiveness	NOUN
biomedich-767	13	8	ratio	ratio	NOUN
biomedich-767	13	9	(	(	PUNCT
biomedich-767	13	10	rp	rp	NOUN
biomedich-767	13	11	/	/	SYM
biomedich-767	13	12	day	day	NOUN
biomedich-767	13	13	/	/	SYM
biomedich-767	13	14	patient	patient	NOUN
biomedich-767	13	15	)	)	PUNCT
biomedich-767	13	16	rp	rp	NOUN
biomedich-767	13	17	.	.	PUNCT
biomedich-767	14	1	1,521,899.195	1,521,899.195	ADV
biomedich-767	14	2	,	,	PUNCT
biomedich-767	14	3	whereas	whereas	SCONJ
biomedich-767	14	4	in	in	ADP
biomedich-767	14	5	patients	patient	NOUN
biomedich-767	14	6	using	use	VERB
biomedich-767	14	7	oseltamivir	oseltamivir	NOUN
biomedich-767	14	8	with	with	ADP
biomedich-767	14	9	an	an	DET
biomedich-767	14	10	average	average	ADJ
biomedich-767	14	11	length	length	NOUN
biomedich-767	14	12	of	of	ADP
biomedich-767	14	13	treatment	treatment	NOUN
biomedich-767	14	14	7.925	7.925	NUM
biomedich-767	14	15	days	day	NOUN
biomedich-767	14	16	,	,	PUNCT
biomedich-767	14	17	the	the	DET
biomedich-767	14	18	total	total	ADJ
biomedich-767	14	19	cost	cost	NOUN
biomedich-767	14	20	was	be	AUX
biomedich-767	14	21	idr	idr	NOUN
biomedich-767	14	22	.	.	PUNCT
biomedich-767	15	1	12,368,397	12,368,397	NUM
biomedich-767	15	2	/	/	SYM
biomedich-767	15	3	patient	patient	ADJ
biomedich-767	15	4	and	and	CCONJ
biomedich-767	15	5	cost	cost	NOUN
biomedich-767	15	6	-	-	PUNCT
biomedich-767	15	7	effectiveness	effectiveness	NOUN
biomedich-767	15	8	ratio	ratio	NOUN
biomedich-767	15	9	(	(	PUNCT
biomedich-767	15	10	rp	rp	NOUN
biomedich-767	15	11	/	/	SYM
biomedich-767	15	12	day	day	NOUN
biomedich-767	15	13	/	/	SYM
biomedich-767	15	14	patient	patient	NOUN
biomedich-767	15	15	)	)	PUNCT
biomedich-767	15	16	idr	idr	PROPN
biomedich-767	15	17	.	.	PUNCT
biomedich-767	15	18	1,560,681,009	1,560,681,009	NUM
biomedich-767	15	19	.	.	PUNCT
biomedich-767	16	1	it	it	PRON
biomedich-767	16	2	can	can	AUX
biomedich-767	16	3	be	be	AUX
biomedich-767	16	4	concluded	conclude	VERB
biomedich-767	16	5	that	that	SCONJ
biomedich-767	16	6	favipiravir	favipiravir	PROPN
biomedich-767	16	7	is	be	AUX
biomedich-767	16	8	more	more	ADJ
biomedich-767	16	9	cost	cost	NOUN
biomedich-767	16	10	effective	effective	ADJ
biomedich-767	16	11	than	than	ADP
biomedich-767	16	12	oseltamivir	oseltamivir	NOUN
biomedich-767	16	13	.	.	PUNCT
biomedich-767	17	1	keywords	keyword	NOUN
biomedich-767	17	2	:	:	PUNCT
biomedich-767	17	3	covid-19	covid-19	PROPN
biomedich-767	17	4	;	;	PUNCT
biomedich-767	17	5	favipiravir	favipiravir	NOUN
biomedich-767	17	6	;	;	PUNCT
biomedich-767	17	7	effective	effective	ADJ
biomedich-767	17	8	and	and	CCONJ
biomedich-767	17	9	efficient	efficient	ADJ
biomedich-767	17	10	;	;	PUNCT
biomedich-767	17	11	oseltamivir	oseltamivir	PROPN
biomedich-767	17	12	.	.	PUNCT
biomedich-767	18	1	introduction	introduction	NOUN
biomedich-767	18	2	corona	corona	PROPN
biomedich-767	18	3	virus	virus	NOUN
biomedich-767	18	4	diseases	disease	VERB
biomedich-767	18	5	2019	2019	NUM
biomedich-767	18	6	(	(	PUNCT
biomedich-767	18	7	covid-19	covid-19	PROPN
biomedich-767	18	8	)	)	PUNCT
biomedich-767	18	9	is	be	AUX
biomedich-767	18	10	a	a	DET
biomedich-767	18	11	disease	disease	NOUN
biomedich-767	18	12	caused	cause	VERB
biomedich-767	18	13	by	by	ADP
biomedich-767	18	14	the	the	DET
biomedich-767	18	15	severe	severe	ADJ
biomedich-767	18	16	acute	acute	ADJ
biomedich-767	18	17	respiratory	respiratory	ADJ
biomedich-767	18	18	syndrome	syndrome	NOUN
biomedich-767	18	19	coronavirus	coronavirus	NOUN
biomedich-767	18	20	2	2	NUM
biomedich-767	18	21	(	(	PUNCT
biomedich-767	18	22	sarcov-2	sarcov-2	NOUN
biomedich-767	18	23	)	)	PUNCT
biomedich-767	18	24	.	.	PUNCT
biomedich-767	19	1	sarcov-2	sarcov-2	NUM
biomedich-767	19	2	is	be	AUX
biomedich-767	19	3	transmitted	transmit	VERB
biomedich-767	19	4	by	by	ADP
biomedich-767	19	5	direct	direct	ADJ
biomedich-767	19	6	contact	contact	NOUN
biomedich-767	19	7	with	with	ADP
biomedich-767	19	8	the	the	DET
biomedich-767	19	9	patient	patient	NOUN
biomedich-767	19	10	through	through	ADP
biomedich-767	19	11	droplets	droplet	NOUN
biomedich-767	19	12	when	when	SCONJ
biomedich-767	19	13	coughing	cough	VERB
biomedich-767	19	14	or	or	CCONJ
biomedich-767	19	15	sneezing	sneeze	VERB
biomedich-767	19	16	,	,	PUNCT
biomedich-767	19	17	as	as	ADV
biomedich-767	19	18	well	well	ADV
biomedich-767	19	19	as	as	ADP
biomedich-767	19	20	hands	hand	NOUN
biomedich-767	19	21	touching	touch	VERB
biomedich-767	19	22	the	the	DET
biomedich-767	19	23	mouth	mouth	NOUN
biomedich-767	19	24	,	,	PUNCT
biomedich-767	19	25	nose	nose	NOUN
biomedich-767	19	26	,	,	PUNCT
biomedich-767	19	27	and	and	CCONJ
biomedich-767	19	28	eyes	eye	NOUN
biomedich-767	19	29	after	after	ADP
biomedich-767	19	30	touching	touch	VERB
biomedich-767	19	31	objects	object	NOUN
biomedich-767	19	32	contaminated	contaminate	VERB
biomedich-767	19	33	with	with	ADP
biomedich-767	19	34	the	the	DET
biomedich-767	19	35	virus	virus	NOUN
biomedich-767	19	36	.	.	PUNCT
biomedich-767	20	1	it	it	PRON
biomedich-767	20	2	first	first	ADV
biomedich-767	20	3	discovered	discover	VERB
biomedich-767	20	4	on	on	ADP
biomedich-767	20	5	december	december	PROPN
biomedich-767	20	6	31	31	NUM
biomedich-767	20	7	,	,	PUNCT
biomedich-767	20	8	2019	2019	NUM
biomedich-767	20	9	.	.	PUNCT
biomedich-767	21	1	in	in	ADP
biomedich-767	21	2	3	3	NUM
biomedich-767	21	3	days	day	NOUN
biomedich-767	21	4	,	,	PUNCT
biomedich-767	21	5	the	the	DET
biomedich-767	21	6	number	number	NOUN
biomedich-767	21	7	of	of	ADP
biomedich-767	21	8	patients	patient	NOUN
biomedich-767	21	9	with	with	ADP
biomedich-767	21	10	these	these	DET
biomedich-767	21	11	cases	case	NOUN
biomedich-767	21	12	amounted	amount	VERB
biomedich-767	21	13	to	to	ADP
biomedich-767	21	14	44	44	NUM
biomedich-767	21	15	and	and	CCONJ
biomedich-767	21	16	has	have	AUX
biomedich-767	21	17	continued	continue	VERB
biomedich-767	21	18	to	to	PART
biomedich-767	21	19	grow	grow	VERB
biomedich-767	21	20	to	to	ADP
biomedich-767	21	21	date	date	NOUN
biomedich-767	21	22	,	,	PUNCT
biomedich-767	21	23	amounting	amount	VERB
biomedich-767	21	24	to	to	ADP
biomedich-767	21	25	millions	million	NOUN
biomedich-767	21	26	of	of	ADP
biomedich-767	21	27	cases	case	NOUN
biomedich-767	21	28	.	.	PUNCT
biomedich-767	22	1	initially	initially	ADV
biomedich-767	22	2	,	,	PUNCT
biomedich-767	22	3	epidemiological	epidemiological	ADJ
biomedich-767	22	4	data	datum	NOUN
biomedich-767	22	5	showed	show	VERB
biomedich-767	22	6	66	66	NUM
biomedich-767	22	7	%	%	NOUN
biomedich-767	22	8	of	of	ADP
biomedich-767	22	9	patients	patient	NOUN
biomedich-767	22	10	were	be	AUX
biomedich-767	22	11	related	relate	VERB
biomedich-767	22	12	to	to	ADP
biomedich-767	22	13	one	one	NUM
biomedich-767	22	14	seafood	seafood	NOUN
biomedich-767	22	15	market	market	NOUN
biomedich-767	22	16	or	or	CCONJ
biomedich-767	22	17	fresh	fresh	ADJ
biomedich-767	22	18	market	market	NOUN
biomedich-767	22	19	in	in	ADP
biomedich-767	22	20	wuhan	wuhan	PROPN
biomedich-767	22	21	,	,	PUNCT
biomedich-767	22	22	hubei	hubei	PROPN
biomedich-767	22	23	province	province	PROPN
biomedich-767	22	24	,	,	PUNCT
biomedich-767	22	25	china	china	PROPN
biomedich-767	22	26	.	.	PUNCT
biomedich-767	23	1	isolate	isolate	VERB
biomedich-767	23	2	samples	sample	NOUN
biomedich-767	23	3	from	from	ADP
biomedich-767	23	4	patients	patient	NOUN
biomedich-767	23	5	were	be	AUX
biomedich-767	23	6	studied	study	VERB
biomedich-767	23	7	,	,	PUNCT
biomedich-767	23	8	with	with	ADP
biomedich-767	23	9	results	result	NOUN
biomedich-767	23	10	showing	show	VERB
biomedich-767	23	11	the	the	DET
biomedich-767	23	12	presence	presence	NOUN
biomedich-767	23	13	of	of	ADP
biomedich-767	23	14	coronavirus	coronavirus	NOUN
biomedich-767	23	15	infection	infection	NOUN
biomedich-767	23	16	,	,	PUNCT
biomedich-767	23	17	a	a	DET
biomedich-767	23	18	new	new	ADJ
biomedich-767	23	19	type	type	NOUN
biomedich-767	23	20	of	of	ADP
biomedich-767	23	21	-coronavirus	-coronavirus	NOUN
biomedich-767	23	22	named	name	VERB
biomedich-767	23	23	novel	novel	ADJ
biomedich-767	23	24	coronavirus	coronavirus	NOUN
biomedich-767	23	25	.	.	PUNCT
biomedich-767	24	1	on	on	ADP
biomedich-767	24	2	march	march	PROPN
biomedich-767	24	3	11	11	NUM
biomedich-767	24	4	,	,	PUNCT
biomedich-767	24	5	2020	2020	NUM
biomedich-767	24	6	,	,	PUNCT
biomedich-767	24	7	who	who	PRON
biomedich-767	24	8	announced	announce	VERB
biomedich-767	24	9	that	that	SCONJ
biomedich-767	24	10	covid-19	covid-19	PROPN
biomedich-767	24	11	had	have	AUX
biomedich-767	24	12	become	become	VERB
biomedich-767	24	13	a	a	DET
biomedich-767	24	14	worldwide	worldwide	ADJ
biomedich-767	24	15	pandemic	pandemic	ADJ
biomedich-767	24	16	(	(	PUNCT
biomedich-767	24	17	lapostolle	lapostolle	NOUN
biomedich-767	24	18	f	f	X
biomedich-767	24	19	et	et	PROPN
biomedich-767	24	20	al	al	PROPN
biomedich-767	24	21	.	.	PROPN
biomedich-767	24	22	2020	2020	NUM
biomedich-767	24	23	,	,	PUNCT
biomedich-767	24	24	lingeswaran	lingeswaran	NOUN
biomedich-767	24	25	m	m	VERB
biomedich-767	24	26	et	et	PROPN
biomedich-767	24	27	al	al	PROPN
biomedich-767	24	28	.	.	PROPN
biomedich-767	24	29	2020	2020	NUM
biomedich-767	24	30	,	,	PUNCT
biomedich-767	24	31	bishnu	bishnu	PROPN
biomedich-767	24	32	p.	p.	PROPN
biomedich-767	24	33	d.	d.	PROPN
biomedich-767	24	34	et	et	PROPN
biomedich-767	24	35	al	al	PROPN
biomedich-767	24	36	.	.	PROPN
biomedich-767	24	37	2020	2020	NUM
biomedich-767	24	38	,	,	PUNCT
biomedich-767	24	39	suresh	suresh	PROPN
biomedich-767	24	40	kumar	kumar	PROPN
biomedich-767	24	41	vc	vc	PROPN
biomedich-767	24	42	et	et	PROPN
biomedich-767	24	43	al	al	PROPN
biomedich-767	24	44	.	.	PROPN
biomedich-767	24	45	2020	2020	NUM
biomedich-767	24	46	,	,	PUNCT
biomedich-767	24	47	di	di	PROPN
biomedich-767	24	48	gennaro	gennaro	PROPN
biomedich-767	24	49	f	f	PROPN
biomedich-767	24	50	et	et	PROPN
biomedich-767	24	51	al	al	PROPN
biomedich-767	24	52	.	.	PROPN
biomedich-767	24	53	2020	2020	NUM
biomedich-767	24	54	)	)	PUNCT
biomedich-767	24	55	the	the	DET
biomedich-767	24	56	first	first	ADJ
biomedich-767	24	57	covid-19	covid-19	PROPN
biomedich-767	24	58	case	case	NOUN
biomedich-767	24	59	in	in	ADP
biomedich-767	24	60	indonesia	indonesia	PROPN
biomedich-767	24	61	was	be	AUX
biomedich-767	24	62	announced	announce	VERB
biomedich-767	24	63	on	on	ADP
biomedich-767	24	64	march	march	PROPN
biomedich-767	24	65	2	2	NUM
biomedich-767	24	66	,	,	PUNCT
biomedich-767	24	67	2020	2020	NUM
biomedich-767	24	68	,	,	PUNCT
biomedich-767	24	69	or	or	CCONJ
biomedich-767	24	70	about	about	ADV
biomedich-767	24	71	4	4	NUM
biomedich-767	24	72	months	month	NOUN
biomedich-767	24	73	after	after	ADP
biomedich-767	24	74	the	the	DET
biomedich-767	24	75	first	first	ADJ
biomedich-767	24	76	case	case	NOUN
biomedich-767	24	77	in	in	ADP
biomedich-767	24	78	china	china	PROPN
biomedich-767	24	79	(	(	PUNCT
biomedich-767	24	80	lingeswaran	lingeswaran	NOUN
biomedich-767	24	81	m	m	VERB
biomedich-767	24	82	et	et	NOUN
biomedich-767	24	83	al	al	PROPN
biomedich-767	24	84	.	.	PROPN
biomedich-767	24	85	2020	2020	NUM
biomedich-767	24	86	)	)	PUNCT
biomedich-767	24	87	.	.	PUNCT
biomedich-767	25	1	at	at	ADP
biomedich-767	25	2	the	the	DET
biomedich-767	25	3	beginning	beginning	NOUN
biomedich-767	25	4	,	,	PUNCT
biomedich-767	25	5	there	there	PRON
biomedich-767	25	6	were	be	VERB
biomedich-767	25	7	hundreds	hundred	NOUN
biomedich-767	25	8	of	of	ADP
biomedich-767	25	9	cases	case	NOUN
biomedich-767	25	10	added	add	VERB
biomedich-767	25	11	,	,	PUNCT
biomedich-767	25	12	and	and	CCONJ
biomedich-767	25	13	until	until	ADP
biomedich-767	25	14	now	now	ADV
biomedich-767	25	15	,	,	PUNCT
biomedich-767	25	16	the	the	DET
biomedich-767	25	17	addition	addition	NOUN
biomedich-767	25	18	of	of	ADP
biomedich-767	25	19	cases	case	NOUN
biomedich-767	25	20	has	have	AUX
biomedich-767	25	21	reached	reach	VERB
biomedich-767	25	22	millions	million	NOUN
biomedich-767	25	23	.	.	PUNCT
biomedich-767	26	1	at	at	ADP
biomedich-767	26	2	the	the	DET
biomedich-767	26	3	time	time	NOUN
biomedich-767	26	4	,	,	PUNCT
biomedich-767	26	5	there	there	PRON
biomedich-767	26	6	were	be	VERB
biomedich-767	26	7	currently	currently	ADV
biomedich-767	26	8	no	no	DET
biomedich-767	26	9	specific	specific	ADJ
biomedich-767	26	10	therapies	therapy	NOUN
biomedich-767	26	11	or	or	CCONJ
biomedich-767	26	12	treatments	treatment	NOUN
biomedich-767	26	13	for	for	ADP
biomedich-767	26	14	covid-19	covid-19	PROPN
biomedich-767	26	15	.	.	PUNCT
biomedich-767	27	1	nevertheless	nevertheless	ADV
biomedich-767	27	2	,	,	PUNCT
biomedich-767	27	3	some	some	DET
biomedich-767	27	4	potential	potential	ADJ
biomedich-767	27	5	drugs	drug	NOUN
biomedich-767	27	6	have	have	AUX
biomedich-767	27	7	been	be	AUX
biomedich-767	27	8	used	use	VERB
biomedich-767	27	9	for	for	ADP
biomedich-767	27	10	people	people	NOUN
biomedich-767	27	11	with	with	ADP
biomedich-767	27	12	covid-19	covid-19	PROPN
biomedich-767	27	13	,	,	PUNCT
biomedich-767	27	14	although	although	SCONJ
biomedich-767	27	15	they	they	PRON
biomedich-767	27	16	are	be	AUX
biomedich-767	27	17	still	still	ADV
biomedich-767	27	18	in	in	ADP
biomedich-767	27	19	test	test	NOUN
biomedich-767	27	20	drug	drug	NOUN
biomedich-767	27	21	status	status	NOUN
biomedich-767	27	22	,	,	PUNCT
biomedich-767	27	23	and	and	CCONJ
biomedich-767	27	24	the	the	DET
biomedich-767	27	25	results	result	NOUN
biomedich-767	27	26	show	show	VERB
biomedich-767	27	27	good	good	ADJ
biomedich-767	27	28	effectiveness	effectiveness	NOUN
biomedich-767	27	29	(	(	PUNCT
biomedich-767	27	30	suresh	suresh	PROPN
biomedich-767	27	31	kumar	kumar	PROPN
biomedich-767	27	32	vc	vc	PROPN
biomedich-767	27	33	et	et	PROPN
biomedich-767	27	34	al	al	PROPN
biomedich-767	27	35	.	.	PROPN
biomedich-767	27	36	2020	2020	NUM
biomedich-767	27	37	)	)	PUNCT
biomedich-767	27	38	.	.	PUNCT
biomedich-767	28	1	for	for	ADP
biomedich-767	28	2	acute	acute	ADJ
biomedich-767	28	3	covid-19	covid-19	PROPN
biomedich-767	28	4	conditions	condition	NOUN
biomedich-767	28	5	and	and	CCONJ
biomedich-767	28	6	molecular	molecular	ADJ
biomedich-767	28	7	detection	detection	NOUN
biomedich-767	28	8	methods	method	NOUN
biomedich-767	28	9	,	,	PUNCT
biomedich-767	28	10	naat	naat	PROPN
biomedich-767	28	11	(	(	PUNCT
biomedich-767	28	12	nucleid	nucleid	NOUN
biomedich-767	28	13	acid	acid	NOUN
biomedich-767	28	14	amplification	amplification	NOUN
biomedich-767	28	15	test	test	NOUN
biomedich-767	28	16	)	)	PUNCT
biomedich-767	28	17	examinations	examination	NOUN
biomedich-767	28	18	,	,	PUNCT
biomedich-767	28	19	including	include	VERB
biomedich-767	28	20	rt	rt	ADJ
biomedich-767	28	21	-	-	PUNCT
biomedich-767	28	22	pcr	pcr	NOUN
biomedich-767	28	23	examinations	examination	NOUN
biomedich-767	28	24	of	of	ADP
biomedich-767	28	25	covid-19	covid-19	PROPN
biomedich-767	28	26	patients	patient	NOUN
biomedich-767	28	27	who	who	PRON
biomedich-767	28	28	are	be	AUX
biomedich-767	28	29	hospitalized	hospitalize	VERB
biomedich-767	28	30	,	,	PUNCT
biomedich-767	28	31	show	show	VERB
biomedich-767	28	32	positive	positive	ADJ
biomedich-767	28	33	results	result	NOUN
biomedich-767	28	34	for	for	ADP
biomedich-767	28	35	antivirals	antiviral	NOUN
biomedich-767	28	36	such	such	ADJ
biomedich-767	28	37	as	as	ADP
biomedich-767	28	38	chloroquinphosphate	chloroquinphosphate	NOUN
biomedich-767	28	39	,	,	PUNCT
biomedich-767	28	40	hydroxychloroquine	hydroxychloroquine	PROPN
biomedich-767	28	41	,	,	PUNCT
biomedich-767	28	42	favipiravir	favipiravir	PROPN
biomedich-767	28	43	,	,	PUNCT
biomedich-767	28	44	oseltamivir	oseltamivir	PROPN
biomedich-767	28	45	,	,	PUNCT
biomedich-767	28	46	remdesivir	remdesivir	NOUN
biomedich-767	28	47	,	,	PUNCT
biomedich-767	28	48	and	and	CCONJ
biomedich-767	28	49	combinations	combination	NOUN
biomedich-767	28	50	between	between	ADP
biomedich-767	28	51	lopinavir	lopinavir	NOUN
biomedich-767	28	52	and	and	CCONJ
biomedich-767	28	53	ritonavir	ritonavir	PROPN
biomedich-767	28	54	(	(	PUNCT
biomedich-767	28	55	suresh	suresh	PROPN
biomedich-767	28	56	kumar	kumar	PROPN
biomedich-767	28	57	vc	vc	PROPN
biomedich-767	28	58	et	et	PROPN
biomedich-767	28	59	al	al	PROPN
biomedich-767	28	60	.	.	PROPN
biomedich-767	28	61	2020	2020	NUM
biomedich-767	28	62	,	,	PUNCT
biomedich-767	28	63	di	di	PROPN
biomedich-767	28	64	gennaro	gennaro	PROPN
biomedich-767	28	65	f	f	PROPN
biomedich-767	28	66	et	et	PROPN
biomedich-767	28	67	al	al	PROPN
biomedich-767	28	68	.	.	PROPN
biomedich-767	28	69	2020	2020	NUM
biomedich-767	28	70	)	)	PUNCT
biomedich-767	28	71	manuscript	manuscript	NOUN
biomedich-767	28	72	received	receive	VERB
biomedich-767	28	73	:	:	PUNCT
biomedich-767	28	74	14	14	NUM
biomedich-767	28	75	april	april	PROPN
biomedich-767	28	76	,	,	PUNCT
biomedich-767	28	77	2025	2025	NUM
biomedich-767	28	78	.	.	PUNCT
biomedich-767	29	1	revision	revision	NOUN
biomedich-767	29	2	accepted	accept	VERB
biomedich-767	29	3	:	:	PUNCT
biomedich-767	29	4	04	04	NUM
biomedich-767	29	5	december	december	NOUN
biomedich-767	29	6	,	,	PUNCT
biomedich-767	29	7	2025	2025	NUM
biomedich-767	29	8	.	.	PUNCT
biomedich-767	30	1	published	publish	VERB
biomedich-767	30	2	:	:	PUNCT
biomedich-767	30	3	11	11	NUM
biomedich-767	30	4	december	december	NOUN
biomedich-767	30	5	,	,	PUNCT
biomedich-767	30	6	2025	2025	NUM
biomedich-767	30	7	.	.	PUNCT
biomedich-767	31	1	https://doi.org/10.14421/biomedich.2025.142.1219-1223	https://doi.org/10.14421/biomedich.2025.142.1219-1223	ADP
biomedich-767	31	2	1220	1220	NUM
biomedich-767	31	3	biology	biology	NOUN
biomedich-767	31	4	,	,	PUNCT
biomedich-767	31	5	medicine	medicine	NOUN
biomedich-767	31	6	,	,	PUNCT
biomedich-767	31	7	&	&	CCONJ
biomedich-767	31	8	natural	natural	ADJ
biomedich-767	31	9	product	product	NOUN
biomedich-767	31	10	chemistry	chemistry	NOUN
biomedich-767	31	11	14	14	NUM
biomedich-767	31	12	(	(	PUNCT
biomedich-767	31	13	2	2	NUM
biomedich-767	31	14	)	)	PUNCT
biomedich-767	31	15	,	,	PUNCT
biomedich-767	31	16	2025	2025	NUM
biomedich-767	31	17	:	:	PUNCT
biomedich-767	31	18	1219	1219	NUM
biomedich-767	31	19	-	-	SYM
biomedich-767	31	20	1223	1223	NUM
biomedich-767	31	21	favipiravir	favipiravir	NOUN
biomedich-767	31	22	is	be	AUX
biomedich-767	31	23	a	a	DET
biomedich-767	31	24	type	type	NOUN
biomedich-767	31	25	of	of	ADP
biomedich-767	31	26	rnadependent	rnadependent	NOUN
biomedich-767	31	27	rna	rna	NOUN
biomedich-767	31	28	polymerase	polymerase	NOUN
biomedich-767	31	29	(	(	PUNCT
biomedich-767	31	30	rdrp	rdrp	NOUN
biomedich-767	31	31	)	)	PUNCT
biomedich-767	31	32	inhibitor	inhibitor	NOUN
biomedich-767	31	33	(	(	PUNCT
biomedich-767	31	34	zhu	zhu	PROPN
biomedich-767	31	35	n	n	CCONJ
biomedich-767	31	36	,	,	PUNCT
biomedich-767	31	37	et	et	PROPN
biomedich-767	31	38	al	al	PROPN
biomedich-767	31	39	.	.	PROPN
biomedich-767	31	40	2019	2019	NUM
biomedich-767	31	41	)	)	PUNCT
biomedich-767	31	42	.	.	PUNCT
biomedich-767	32	1	on	on	ADP
biomedich-767	32	2	february	february	PROPN
biomedich-767	32	3	14	14	NUM
biomedich-767	32	4	,	,	PUNCT
biomedich-767	32	5	a	a	DET
biomedich-767	32	6	clinical	clinical	ADJ
biomedich-767	32	7	trial	trial	NOUN
biomedich-767	32	8	of	of	ADP
biomedich-767	32	9	favipiravir	favipiravir	NOUN
biomedich-767	32	10	for	for	ADP
biomedich-767	32	11	the	the	DET
biomedich-767	32	12	treatment	treatment	NOUN
biomedich-767	32	13	of	of	ADP
biomedich-767	32	14	covid-19	covid-19	PROPN
biomedich-767	32	15	was	be	AUX
biomedich-767	32	16	initiated	initiate	VERB
biomedich-767	32	17	by	by	ADP
biomedich-767	32	18	the	the	DET
biomedich-767	32	19	clinical	clinical	ADJ
biomedich-767	32	20	medical	medical	ADJ
biomedich-767	32	21	research	research	NOUN
biomedich-767	32	22	center	center	NOUN
biomedich-767	32	23	of	of	ADP
biomedich-767	32	24	the	the	DET
biomedich-767	32	25	third	third	ADJ
biomedich-767	32	26	people	people	NOUN
biomedich-767	32	27	's	's	PART
biomedich-767	32	28	hospital	hospital	NOUN
biomedich-767	32	29	of	of	ADP
biomedich-767	32	30	shenzhen	shenzhen	PROPN
biomedich-767	32	31	.	.	PUNCT
biomedich-767	33	1	preliminary	preliminary	ADJ
biomedich-767	33	2	results	result	NOUN
biomedich-767	33	3	from	from	ADP
biomedich-767	33	4	a	a	DET
biomedich-767	33	5	total	total	NOUN
biomedich-767	33	6	of	of	ADP
biomedich-767	33	7	80	80	NUM
biomedich-767	33	8	patients	patient	NOUN
biomedich-767	33	9	(	(	PUNCT
biomedich-767	33	10	including	include	VERB
biomedich-767	33	11	the	the	DET
biomedich-767	33	12	experimental	experimental	ADJ
biomedich-767	33	13	group	group	NOUN
biomedich-767	33	14	and	and	CCONJ
biomedich-767	33	15	the	the	DET
biomedich-767	33	16	control	control	NOUN
biomedich-767	33	17	group	group	NOUN
biomedich-767	33	18	)	)	PUNCT
biomedich-767	33	19	showed	show	VERB
biomedich-767	33	20	that	that	SCONJ
biomedich-767	33	21	favipiravir	favipiravir	PROPN
biomedich-767	33	22	had	have	VERB
biomedich-767	33	23	a	a	DET
biomedich-767	33	24	stronger	strong	ADJ
biomedich-767	33	25	effect	effect	NOUN
biomedich-767	33	26	compared	compare	VERB
biomedich-767	33	27	to	to	ADP
biomedich-767	33	28	lopinavir	lopinavir	PROPN
biomedich-767	33	29	and	and	CCONJ
biomedich-767	33	30	ritonavir	ritonavir	PROPN
biomedich-767	33	31	.	.	PUNCT
biomedich-767	34	1	there	there	PRON
biomedich-767	34	2	were	be	VERB
biomedich-767	34	3	no	no	DET
biomedich-767	34	4	adverse	adverse	ADJ
biomedich-767	34	5	reactions	reaction	NOUN
biomedich-767	34	6	or	or	CCONJ
biomedich-767	34	7	significant	significant	ADJ
biomedich-767	34	8	side	side	NOUN
biomedich-767	34	9	effects	effect	NOUN
biomedich-767	34	10	in	in	ADP
biomedich-767	34	11	the	the	DET
biomedich-767	34	12	favipiravir	favipiravir	PROPN
biomedich-767	34	13	treatment	treatment	NOUN
biomedich-767	34	14	group	group	NOUN
biomedich-767	34	15	compared	compare	VERB
biomedich-767	34	16	to	to	ADP
biomedich-767	34	17	the	the	DET
biomedich-767	34	18	lopinavir	lopinavir	PROPN
biomedich-767	34	19	/	/	SYM
biomedich-767	34	20	ritonavir	ritonavir	PROPN
biomedich-767	34	21	group	group	NOUN
biomedich-767	34	22	(	(	PUNCT
biomedich-767	34	23	suresh	suresh	PROPN
biomedich-767	34	24	kumar	kumar	PROPN
biomedich-767	34	25	vc	vc	PROPN
biomedich-767	34	26	,	,	PUNCT
biomedich-767	34	27	et	et	PROPN
biomedich-767	34	28	al	al	PROPN
biomedich-767	34	29	.	.	PROPN
biomedich-767	34	30	2020	2020	NUM
biomedich-767	34	31	)	)	PUNCT
biomedich-767	34	32	.	.	PUNCT
biomedich-767	35	1	oseltamivir	oseltamivir	PROPN
biomedich-767	35	2	is	be	AUX
biomedich-767	35	3	part	part	NOUN
biomedich-767	35	4	of	of	ADP
biomedich-767	35	5	the	the	DET
biomedich-767	35	6	class	class	NOUN
biomedich-767	35	7	of	of	ADP
biomedich-767	35	8	neuraminidase	neuraminidase	NOUN
biomedich-767	35	9	inhibitors	inhibitor	NOUN
biomedich-767	35	10	(	(	PUNCT
biomedich-767	35	11	nais	nais	NOUN
biomedich-767	35	12	)	)	PUNCT
biomedich-767	35	13	,	,	PUNCT
biomedich-767	35	14	which	which	PRON
biomedich-767	35	15	have	have	VERB
biomedich-767	35	16	a	a	DET
biomedich-767	35	17	mechanism	mechanism	NOUN
biomedich-767	35	18	of	of	ADP
biomedich-767	35	19	action	action	NOUN
biomedich-767	35	20	by	by	ADP
biomedich-767	35	21	inhibiting	inhibit	VERB
biomedich-767	35	22	viral	viral	ADJ
biomedich-767	35	23	neuraminidase	neuraminidase	NOUN
biomedich-767	35	24	and	and	CCONJ
biomedich-767	35	25	inhibiting	inhibit	VERB
biomedich-767	35	26	the	the	DET
biomedich-767	35	27	release	release	NOUN
biomedich-767	35	28	of	of	ADP
biomedich-767	35	29	virus	virus	NOUN
biomedich-767	35	30	particles	particle	NOUN
biomedich-767	35	31	from	from	ADP
biomedich-767	35	32	infected	infected	ADJ
biomedich-767	35	33	cells	cell	NOUN
biomedich-767	35	34	so	so	SCONJ
biomedich-767	35	35	as	as	SCONJ
biomedich-767	35	36	to	to	PART
biomedich-767	35	37	reduce	reduce	VERB
biomedich-767	35	38	the	the	DET
biomedich-767	35	39	spread	spread	NOUN
biomedich-767	35	40	of	of	ADP
biomedich-767	35	41	the	the	DET
biomedich-767	35	42	virus	virus	NOUN
biomedich-767	35	43	in	in	ADP
biomedich-767	35	44	the	the	DET
biomedich-767	35	45	airway	airway	NOUN
biomedich-767	35	46	(	(	PUNCT
biomedich-767	35	47	susilo	susilo	VERB
biomedich-767	35	48	a	a	PRON
biomedich-767	35	49	,	,	PUNCT
biomedich-767	35	50	et	et	PROPN
biomedich-767	35	51	al	al	PROPN
biomedich-767	35	52	.	.	PROPN
biomedich-767	35	53	2019	2019	NUM
biomedich-767	35	54	.	.	PUNCT
biomedich-767	36	1	y	y	PROPN
biomedich-767	36	2	furuta	furuta	PROPN
biomedich-767	36	3	,	,	PUNCT
biomedich-767	36	4	et	et	PROPN
biomedich-767	36	5	al	al	PROPN
biomedich-767	36	6	.	.	PROPN
biomedich-767	36	7	2017	2017	NUM
biomedich-767	36	8	,	,	PUNCT
biomedich-767	36	9	uyeki	uyeki	VERB
biomedich-767	36	10	tm	tm	PROPN
biomedich-767	36	11	2018	2018	NUM
biomedich-767	36	12	)	)	PUNCT
biomedich-767	36	13	this	this	DET
biomedich-767	36	14	covid-19	covid-19	PROPN
biomedich-767	36	15	disease	disease	NOUN
biomedich-767	36	16	requires	require	VERB
biomedich-767	36	17	a	a	DET
biomedich-767	36	18	very	very	ADV
biomedich-767	36	19	large	large	ADJ
biomedich-767	36	20	hospitalization	hospitalization	NOUN
biomedich-767	36	21	cost	cost	NOUN
biomedich-767	36	22	of	of	ADP
biomedich-767	36	23	around	around	ADP
biomedich-767	36	24	rp	rp	NOUN
biomedich-767	36	25	.	.	PROPN
biomedich-767	37	1	17,808,650	17,808,650	NUM
biomedich-767	37	2	per	per	ADP
biomedich-767	37	3	patient	patient	NOUN
biomedich-767	37	4	;	;	PUNCT
biomedich-767	37	5	this	this	DET
biomedich-767	37	6	value	value	NOUN
biomedich-767	37	7	is	be	AUX
biomedich-767	37	8	calculated	calculate	VERB
biomedich-767	37	9	from	from	ADP
biomedich-767	37	10	the	the	DET
biomedich-767	37	11	costs	cost	NOUN
biomedich-767	37	12	of	of	ADP
biomedich-767	37	13	drugs	drug	NOUN
biomedich-767	37	14	,	,	PUNCT
biomedich-767	37	15	treatments	treatment	NOUN
biomedich-767	37	16	,	,	PUNCT
biomedich-767	37	17	laboratories	laboratory	NOUN
biomedich-767	37	18	,	,	PUNCT
biomedich-767	37	19	and	and	CCONJ
biomedich-767	37	20	radiology	radiology	NOUN
biomedich-767	37	21	(	(	PUNCT
biomedich-767	37	22	di	di	X
biomedich-767	37	23	gennaro	gennaro	PROPN
biomedich-767	37	24	f	f	PROPN
biomedich-767	37	25	et	et	PROPN
biomedich-767	37	26	al	al	PROPN
biomedich-767	37	27	.	.	PROPN
biomedich-767	37	28	2020	2020	NUM
biomedich-767	37	29	)	)	PUNCT
biomedich-767	37	30	.	.	PUNCT
biomedich-767	38	1	to	to	PART
biomedich-767	38	2	meet	meet	VERB
biomedich-767	38	3	the	the	DET
biomedich-767	38	4	needs	need	NOUN
biomedich-767	38	5	of	of	ADP
biomedich-767	38	6	quality	quality	NOUN
biomedich-767	38	7	and	and	CCONJ
biomedich-767	38	8	cost	cost	NOUN
biomedich-767	38	9	-	-	PUNCT
biomedich-767	38	10	effective	effective	ADJ
biomedich-767	38	11	health	health	NOUN
biomedich-767	38	12	,	,	PUNCT
biomedich-767	38	13	the	the	DET
biomedich-767	38	14	cost	cost	NOUN
biomedich-767	38	15	of	of	ADP
biomedich-767	38	16	treatment	treatment	NOUN
biomedich-767	38	17	must	must	AUX
biomedich-767	38	18	be	be	AUX
biomedich-767	38	19	more	more	ADV
biomedich-767	38	20	affordable	affordable	ADJ
biomedich-767	38	21	for	for	ADP
biomedich-767	38	22	the	the	DET
biomedich-767	38	23	community	community	NOUN
biomedich-767	38	24	and	and	CCONJ
biomedich-767	38	25	effective	effective	ADJ
biomedich-767	38	26	to	to	PART
biomedich-767	38	27	get	get	VERB
biomedich-767	38	28	clinical	clinical	ADJ
biomedich-767	38	29	results	result	NOUN
biomedich-767	38	30	.	.	PUNCT
biomedich-767	39	1	good	good	ADJ
biomedich-767	39	2	is	be	AUX
biomedich-767	39	3	a	a	DET
biomedich-767	39	4	negative	negative	ADJ
biomedich-767	39	5	rt	rt	ADJ
biomedich-767	39	6	-	-	PUNCT
biomedich-767	39	7	pcr	pcr	ADJ
biomedich-767	39	8	value	value	NOUN
biomedich-767	39	9	,	,	PUNCT
biomedich-767	39	10	and	and	CCONJ
biomedich-767	39	11	without	without	ADP
biomedich-767	39	12	drug	drug	NOUN
biomedich-767	39	13	side	side	NOUN
biomedich-767	39	14	effects	effect	NOUN
biomedich-767	39	15	,	,	PUNCT
biomedich-767	39	16	health	health	NOUN
biomedich-767	39	17	policy	policy	NOUN
biomedich-767	39	18	should	should	AUX
biomedich-767	39	19	go	go	VERB
biomedich-767	39	20	through	through	ADP
biomedich-767	39	21	appropriate	appropriate	ADJ
biomedich-767	39	22	economic	economic	ADJ
biomedich-767	39	23	evaluation	evaluation	NOUN
biomedich-767	39	24	(	(	PUNCT
biomedich-767	39	25	lingeswaran	lingeswaran	NOUN
biomedich-767	39	26	m	m	PROPN
biomedich-767	39	27	et	et	NOUN
biomedich-767	39	28	al	al	PROPN
biomedich-767	39	29	.	.	PROPN
biomedich-767	39	30	2020	2020	NUM
biomedich-767	39	31	,	,	PUNCT
biomedich-767	39	32	di	di	PROPN
biomedich-767	39	33	gennaro	gennaro	PROPN
biomedich-767	39	34	f	f	PROPN
biomedich-767	39	35	et	et	PROPN
biomedich-767	39	36	al	al	PROPN
biomedich-767	39	37	.	.	PROPN
biomedich-767	39	38	2020	2020	NUM
biomedich-767	39	39	)	)	PUNCT
biomedich-767	39	40	.	.	PUNCT
biomedich-767	40	1	in	in	ADP
biomedich-767	40	2	august	august	PROPN
biomedich-767	40	3	2022	2022	NUM
biomedich-767	40	4	,	,	PUNCT
biomedich-767	40	5	who	who	PRON
biomedich-767	40	6	no	no	ADV
biomedich-767	40	7	longer	long	ADV
biomedich-767	40	8	lists	list	VERB
biomedich-767	40	9	oseltamivir	oseltamivir	PROPN
biomedich-767	40	10	as	as	ADP
biomedich-767	40	11	clinical	clinical	ADJ
biomedich-767	40	12	management	management	NOUN
biomedich-767	40	13	of	of	ADP
biomedich-767	40	14	covid-19	covid-19	PROPN
biomedich-767	40	15	in	in	ADP
biomedich-767	40	16	health	health	NOUN
biomedich-767	40	17	facilities	facility	NOUN
biomedich-767	40	18	.	.	PUNCT
biomedich-767	41	1	study	study	NOUN
biomedich-767	41	2	results	result	NOUN
biomedich-767	41	3	show	show	VERB
biomedich-767	41	4	that	that	SCONJ
biomedich-767	41	5	oseltamivir	oseltamivir	PROPN
biomedich-767	41	6	is	be	AUX
biomedich-767	41	7	not	not	PART
biomedich-767	41	8	effective	effective	ADJ
biomedich-767	41	9	against	against	ADP
biomedich-767	41	10	sarscov-2	sarscov-2	NUM
biomedich-767	41	11	in	in	ADP
biomedich-767	41	12	both	both	CCONJ
biomedich-767	41	13	in	in	ADP
biomedich-767	41	14	vitro	vitro	X
biomedich-767	41	15	testing	testing	NOUN
biomedich-767	41	16	and	and	CCONJ
biomedich-767	41	17	case	case	NOUN
biomedich-767	41	18	reports	report	NOUN
biomedich-767	41	19	in	in	ADP
biomedich-767	41	20	covid-19	covid-19	PROPN
biomedich-767	41	21	patients	patient	NOUN
biomedich-767	41	22	(	(	PUNCT
biomedich-767	41	23	uyeki	uyeki	VERB
biomedich-767	41	24	tm	tm	PROPN
biomedich-767	41	25	2018	2018	NUM
biomedich-767	41	26	)	)	PUNCT
biomedich-767	41	27	.	.	PUNCT
biomedich-767	42	1	in	in	ADP
biomedich-767	42	2	choosing	choose	VERB
biomedich-767	42	3	the	the	DET
biomedich-767	42	4	priority	priority	NOUN
biomedich-767	42	5	of	of	ADP
biomedich-767	42	6	the	the	DET
biomedich-767	42	7	covid-19	covid-19	PROPN
biomedich-767	42	8	treatment	treatment	NOUN
biomedich-767	42	9	strategy	strategy	NOUN
biomedich-767	42	10	using	use	VERB
biomedich-767	42	11	antiretrovirals	antiretroviral	NOUN
biomedich-767	42	12	,	,	PUNCT
biomedich-767	42	13	favipiravir	favipiravir	PROPN
biomedich-767	42	14	and	and	CCONJ
biomedich-767	42	15	oseltamivir	oseltamivir	PROPN
biomedich-767	42	16	,	,	PUNCT
biomedich-767	42	17	which	which	PRON
biomedich-767	42	18	provide	provide	VERB
biomedich-767	42	19	the	the	DET
biomedich-767	42	20	largest	large	ADJ
biomedich-767	42	21	rational	rational	ADJ
biomedich-767	42	22	treatment	treatment	NOUN
biomedich-767	42	23	outcomes	outcome	NOUN
biomedich-767	42	24	,	,	PUNCT
biomedich-767	42	25	it	it	PRON
biomedich-767	42	26	is	be	AUX
biomedich-767	42	27	necessary	necessary	ADJ
biomedich-767	42	28	to	to	PART
biomedich-767	42	29	conduct	conduct	VERB
biomedich-767	42	30	a	a	DET
biomedich-767	42	31	costeffectiveness	costeffectiveness	NOUN
biomedich-767	42	32	assessment	assessment	NOUN
biomedich-767	42	33	analysis	analysis	NOUN
biomedich-767	42	34	using	use	VERB
biomedich-767	42	35	the	the	DET
biomedich-767	42	36	aeb	aeb	NOUN
biomedich-767	42	37	method	method	NOUN
biomedich-767	42	38	,	,	PUNCT
biomedich-767	42	39	which	which	PRON
biomedich-767	42	40	is	be	AUX
biomedich-767	42	41	very	very	ADV
biomedich-767	42	42	good	good	ADJ
biomedich-767	42	43	to	to	PART
biomedich-767	42	44	provide	provide	VERB
biomedich-767	42	45	the	the	DET
biomedich-767	42	46	best	good	ADJ
biomedich-767	42	47	therapeutic	therapeutic	ADJ
biomedich-767	42	48	recommendations	recommendation	NOUN
biomedich-767	42	49	,	,	PUNCT
biomedich-767	42	50	estimate	estimate	VERB
biomedich-767	42	51	health	health	NOUN
biomedich-767	42	52	progress	progress	NOUN
biomedich-767	42	53	,	,	PUNCT
biomedich-767	42	54	and	and	CCONJ
biomedich-767	42	55	determine	determine	VERB
biomedich-767	42	56	the	the	DET
biomedich-767	42	57	most	most	ADV
biomedich-767	42	58	effective	effective	ADJ
biomedich-767	42	59	cost	cost	NOUN
biomedich-767	42	60	for	for	ADP
biomedich-767	42	61	covid-19	covid-19	PROPN
biomedich-767	42	62	treatment	treatment	NOUN
biomedich-767	42	63	that	that	PRON
biomedich-767	42	64	relates	relate	VERB
biomedich-767	42	65	the	the	DET
biomedich-767	42	66	costs	cost	NOUN
biomedich-767	42	67	needed	need	VERB
biomedich-767	42	68	with	with	ADP
biomedich-767	42	69	the	the	DET
biomedich-767	42	70	outcomes	outcome	NOUN
biomedich-767	42	71	produced	produce	VERB
biomedich-767	42	72	(	(	PUNCT
biomedich-767	42	73	y	y	PROPN
biomedich-767	42	74	furuta	furuta	PROPN
biomedich-767	42	75	,	,	PUNCT
biomedich-767	42	76	et	et	PROPN
biomedich-767	42	77	al	al	PROPN
biomedich-767	42	78	.	.	PROPN
biomedich-767	42	79	2017	2017	NUM
biomedich-767	42	80	)	)	PUNCT
biomedich-767	42	81	.	.	PUNCT
biomedich-767	43	1	this	this	DET
biomedich-767	43	2	research	research	NOUN
biomedich-767	43	3	is	be	AUX
biomedich-767	43	4	expected	expect	VERB
biomedich-767	43	5	to	to	PART
biomedich-767	43	6	provide	provide	VERB
biomedich-767	43	7	benefits	benefit	NOUN
biomedich-767	43	8	for	for	ADP
biomedich-767	43	9	the	the	DET
biomedich-767	43	10	nation	nation	NOUN
biomedich-767	43	11	and	and	CCONJ
biomedich-767	43	12	state	state	NOUN
biomedich-767	43	13	in	in	ADP
biomedich-767	43	14	determining	determine	VERB
biomedich-767	43	15	the	the	DET
biomedich-767	43	16	choice	choice	NOUN
biomedich-767	43	17	of	of	ADP
biomedich-767	43	18	quality	quality	NOUN
biomedich-767	43	19	and	and	CCONJ
biomedich-767	43	20	costeffective	costeffective	ADJ
biomedich-767	43	21	antiretroviral	antiretroviral	ADJ
biomedich-767	43	22	drugs	drug	NOUN
biomedich-767	43	23	,	,	PUNCT
biomedich-767	43	24	especially	especially	ADV
biomedich-767	43	25	as	as	ADP
biomedich-767	43	26	a	a	DET
biomedich-767	43	27	consideration	consideration	NOUN
biomedich-767	43	28	for	for	ADP
biomedich-767	43	29	policy	policy	NOUN
biomedich-767	43	30	formulation	formulation	NOUN
biomedich-767	43	31	for	for	ADP
biomedich-767	43	32	the	the	DET
biomedich-767	43	33	ministry	ministry	PROPN
biomedich-767	43	34	of	of	ADP
biomedich-767	43	35	health	health	PROPN
biomedich-767	43	36	in	in	ADP
biomedich-767	43	37	determining	determine	VERB
biomedich-767	43	38	the	the	DET
biomedich-767	43	39	cost	cost	NOUN
biomedich-767	43	40	of	of	ADP
biomedich-767	43	41	covid-19	covid-19	PROPN
biomedich-767	43	42	treatment	treatment	NOUN
biomedich-767	43	43	and	and	CCONJ
biomedich-767	43	44	the	the	DET
biomedich-767	43	45	resulting	result	VERB
biomedich-767	43	46	outcomes	outcome	NOUN
biomedich-767	43	47	(	(	PUNCT
biomedich-767	43	48	y	y	PROPN
biomedich-767	43	49	furuta	furuta	PROPN
biomedich-767	43	50	,	,	PUNCT
biomedich-767	43	51	et	et	PROPN
biomedich-767	43	52	al	al	PROPN
biomedich-767	43	53	.	.	PROPN
biomedich-767	43	54	2017	2017	NUM
biomedich-767	43	55	)	)	PUNCT
biomedich-767	43	56	.	.	PUNCT
biomedich-767	44	1	materials	material	NOUN
biomedich-767	44	2	and	and	CCONJ
biomedich-767	44	3	methods	method	NOUN
biomedich-767	44	4	we	we	PRON
biomedich-767	44	5	used	use	VERB
biomedich-767	44	6	pharmacoeconomic	pharmacoeconomic	ADJ
biomedich-767	44	7	methods	method	NOUN
biomedich-767	44	8	that	that	PRON
biomedich-767	44	9	involve	involve	VERB
biomedich-767	44	10	effectiveness	effectiveness	NOUN
biomedich-767	44	11	analysis	analysis	NOUN
biomedich-767	44	12	with	with	ADP
biomedich-767	44	13	a	a	DET
biomedich-767	44	14	cross	cross	ADJ
biomedich-767	44	15	-	-	ADJ
biomedich-767	44	16	sectional	sectional	ADJ
biomedich-767	44	17	research	research	NOUN
biomedich-767	44	18	design	design	NOUN
biomedich-767	44	19	(	(	PUNCT
biomedich-767	44	20	crosssectional	crosssectional	NOUN
biomedich-767	44	21	)	)	PUNCT
biomedich-767	44	22	and	and	CCONJ
biomedich-767	44	23	retrospective	retrospective	ADJ
biomedich-767	44	24	data	datum	NOUN
biomedich-767	44	25	search	search	NOUN
biomedich-767	44	26	,	,	PUNCT
biomedich-767	44	27	the	the	DET
biomedich-767	44	28	parameter	parameter	NOUN
biomedich-767	44	29	measured	measure	VERB
biomedich-767	44	30	was	be	AUX
biomedich-767	44	31	rt	rt	ADJ
biomedich-767	44	32	-	-	PUNCT
biomedich-767	44	33	pcr	pcr	ADJ
biomedich-767	44	34	negative	negative	NOUN
biomedich-767	44	35	.	.	PUNCT
biomedich-767	45	1	results	result	NOUN
biomedich-767	45	2	are	be	AUX
biomedich-767	45	3	presented	present	VERB
biomedich-767	45	4	in	in	ADP
biomedich-767	45	5	a	a	DET
biomedich-767	45	6	descriptiveanalytic	descriptiveanalytic	ADJ
biomedich-767	45	7	manner	manner	NOUN
biomedich-767	45	8	.	.	PUNCT
biomedich-767	46	1	the	the	DET
biomedich-767	46	2	subjects	subject	NOUN
biomedich-767	46	3	of	of	ADP
biomedich-767	46	4	this	this	DET
biomedich-767	46	5	study	study	NOUN
biomedich-767	46	6	were	be	AUX
biomedich-767	46	7	inpatient	inpatient	PROPN
biomedich-767	46	8	covid-19	covid-19	PROPN
biomedich-767	46	9	patients	patient	NOUN
biomedich-767	46	10	using	use	VERB
biomedich-767	46	11	anti	anti	ADJ
biomedich-767	46	12	-	-	ADJ
biomedich-767	46	13	retroviral	retroviral	ADJ
biomedich-767	46	14	favipiravir	favipiravir	NOUN
biomedich-767	46	15	and	and	CCONJ
biomedich-767	46	16	oseltamivir	oseltamivir	PROPN
biomedich-767	46	17	at	at	ADP
biomedich-767	46	18	cisarua	cisarua	PROPN
biomedich-767	46	19	lung	lung	PROPN
biomedich-767	46	20	hospital	hospital	NOUN
biomedich-767	46	21	,	,	PUNCT
biomedich-767	46	22	bogor	bogor	NOUN
biomedich-767	46	23	,	,	PUNCT
biomedich-767	46	24	for	for	ADP
biomedich-767	46	25	the	the	DET
biomedich-767	46	26	period	period	NOUN
biomedich-767	46	27	septemberoctober	septemberoctober	NOUN
biomedich-767	46	28	2022	2022	NUM
biomedich-767	46	29	.	.	PUNCT
biomedich-767	47	1	the	the	DET
biomedich-767	47	2	inclusion	inclusion	NOUN
biomedich-767	47	3	criteria	criterion	NOUN
biomedich-767	47	4	in	in	ADP
biomedich-767	47	5	this	this	DET
biomedich-767	47	6	study	study	NOUN
biomedich-767	47	7	were	be	AUX
biomedich-767	47	8	adult	adult	NOUN
biomedich-767	47	9	covid19	covid19	NOUN
biomedich-767	47	10	:	:	PUNCT
biomedich-767	47	11	p	p	X
biomedich-767	47	12	>	>	X
biomedich-767	47	13	17	17	NUM
biomedich-767	47	14	years	year	NOUN
biomedich-767	47	15	,	,	PUNCT
biomedich-767	47	16	hospitalized	hospitalize	VERB
biomedich-767	47	17	patients	patient	NOUN
biomedich-767	47	18	diagnosed	diagnose	VERB
biomedich-767	47	19	with	with	ADP
biomedich-767	47	20	moderate	moderate	ADJ
biomedich-767	47	21	covid-19	covid-19	PROPN
biomedich-767	47	22	by	by	ADP
biomedich-767	47	23	doctors	doctor	NOUN
biomedich-767	47	24	(	(	PUNCT
biomedich-767	47	25	positive	positive	ADJ
biomedich-767	47	26	rtpcr	rtpcr	ADJ
biomedich-767	47	27	value	value	NOUN
biomedich-767	47	28	(	(	PUNCT
biomedich-767	47	29	ct	ct	NOUN
biomedich-767	47	30	<	<	X
biomedich-767	47	31	40	40	NUM
biomedich-767	47	32	)	)	PUNCT
biomedich-767	47	33	,	,	PUNCT
biomedich-767	47	34	patients	patient	NOUN
biomedich-767	47	35	undergoing	undergo	VERB
biomedich-767	47	36	treatment	treatment	NOUN
biomedich-767	47	37	in	in	ADP
biomedich-767	47	38	july	july	PROPN
biomedich-767	47	39	–	–	PUNCT
biomedich-767	47	40	december	december	PROPN
biomedich-767	47	41	2021	2021	NUM
biomedich-767	47	42	,	,	PUNCT
biomedich-767	47	43	receiving	receive	VERB
biomedich-767	47	44	antiretroviral	antiretroviral	ADJ
biomedich-767	47	45	therapy	therapy	NOUN
biomedich-767	47	46	favipiravir	favipiravir	NOUN
biomedich-767	47	47	and	and	CCONJ
biomedich-767	47	48	oseltamivir	oseltamivir	PROPN
biomedich-767	47	49	.	.	PUNCT
biomedich-767	48	1	the	the	DET
biomedich-767	48	2	inclusion	inclusion	NOUN
biomedich-767	48	3	criteria	criterion	NOUN
biomedich-767	48	4	were	be	AUX
biomedich-767	48	5	as	as	SCONJ
biomedich-767	48	6	follows	follow	VERB
biomedich-767	48	7	:	:	PUNCT
biomedich-767	48	8	pregnant	pregnant	ADJ
biomedich-767	48	9	women	woman	NOUN
biomedich-767	48	10	,	,	PUNCT
biomedich-767	48	11	patients	patient	NOUN
biomedich-767	48	12	with	with	ADP
biomedich-767	48	13	unrecorded	unrecorded	ADJ
biomedich-767	48	14	medical	medical	ADJ
biomedich-767	48	15	records	record	NOUN
biomedich-767	48	16	of	of	ADP
biomedich-767	48	17	antiretrovirals	antiretroviral	NOUN
biomedich-767	48	18	used	use	VERB
biomedich-767	48	19	(	(	PUNCT
biomedich-767	48	20	type	type	NOUN
biomedich-767	48	21	,	,	PUNCT
biomedich-767	48	22	dose	dose	NOUN
biomedich-767	48	23	,	,	PUNCT
biomedich-767	48	24	and	and	CCONJ
biomedich-767	48	25	frequency	frequency	NOUN
biomedich-767	48	26	of	of	ADP
biomedich-767	48	27	administration	administration	NOUN
biomedich-767	48	28	)	)	PUNCT
biomedich-767	48	29	and	and	CCONJ
biomedich-767	48	30	no	no	DET
biomedich-767	48	31	recorded	record	VERB
biomedich-767	48	32	pcr	pcr	ADJ
biomedich-767	48	33	examination	examination	NOUN
biomedich-767	48	34	,	,	PUNCT
biomedich-767	48	35	patients	patient	NOUN
biomedich-767	48	36	admitted	admit	VERB
biomedich-767	48	37	to	to	ADP
biomedich-767	48	38	the	the	DET
biomedich-767	48	39	icu	icu	PROPN
biomedich-767	48	40	during	during	ADP
biomedich-767	48	41	the	the	DET
biomedich-767	48	42	study	study	NOUN
biomedich-767	48	43	process	process	NOUN
biomedich-767	48	44	,	,	PUNCT
biomedich-767	48	45	and	and	CCONJ
biomedich-767	48	46	patients	patient	NOUN
biomedich-767	48	47	who	who	PRON
biomedich-767	48	48	died	die	VERB
biomedich-767	48	49	during	during	ADP
biomedich-767	48	50	the	the	DET
biomedich-767	48	51	study	study	NOUN
biomedich-767	48	52	process	process	NOUN
biomedich-767	48	53	.	.	PUNCT
biomedich-767	49	1	the	the	DET
biomedich-767	49	2	materials	material	NOUN
biomedich-767	49	3	used	use	VERB
biomedich-767	49	4	were	be	AUX
biomedich-767	49	5	medical	medical	ADJ
biomedich-767	49	6	records	record	NOUN
biomedich-767	49	7	and	and	CCONJ
biomedich-767	49	8	details	detail	NOUN
biomedich-767	49	9	of	of	ADP
biomedich-767	49	10	medical	medical	ADJ
biomedich-767	49	11	costs	cost	NOUN
biomedich-767	49	12	for	for	ADP
biomedich-767	49	13	covid-19	covid-19	PROPN
biomedich-767	49	14	patients	patient	NOUN
biomedich-767	49	15	at	at	ADP
biomedich-767	49	16	cisarua	cisarua	PROPN
biomedich-767	49	17	bogor	bogor	PROPN
biomedich-767	49	18	lung	lung	PROPN
biomedich-767	49	19	hospital	hospital	NOUN
biomedich-767	49	20	.	.	PUNCT
biomedich-767	50	1	the	the	DET
biomedich-767	50	2	samples	sample	NOUN
biomedich-767	50	3	used	use	VERB
biomedich-767	50	4	were	be	AUX
biomedich-767	50	5	80	80	NUM
biomedich-767	50	6	medical	medical	ADJ
biomedich-767	50	7	records	record	NOUN
biomedich-767	50	8	,	,	PUNCT
biomedich-767	50	9	consisting	consist	VERB
biomedich-767	50	10	of	of	ADP
biomedich-767	50	11	40	40	NUM
biomedich-767	50	12	medical	medical	ADJ
biomedich-767	50	13	records	record	NOUN
biomedich-767	50	14	of	of	ADP
biomedich-767	50	15	patients	patient	NOUN
biomedich-767	50	16	using	use	VERB
biomedich-767	50	17	favipiravir	favipiravir	PROPN
biomedich-767	50	18	antiretrovirals	antiretroviral	NOUN
biomedich-767	50	19	and	and	CCONJ
biomedich-767	50	20	40	40	NUM
biomedich-767	50	21	medical	medical	ADJ
biomedich-767	50	22	records	record	NOUN
biomedich-767	50	23	of	of	ADP
biomedich-767	50	24	patients	patient	NOUN
biomedich-767	50	25	using	use	VERB
biomedich-767	50	26	oseltamivir	oseltamivir	PROPN
biomedich-767	50	27	antiretrovirals	antiretroviral	NOUN
biomedich-767	50	28	.	.	PUNCT
biomedich-767	51	1	in	in	ADP
biomedich-767	51	2	this	this	DET
biomedich-767	51	3	study	study	NOUN
biomedich-767	51	4	,	,	PUNCT
biomedich-767	51	5	researchers	researcher	NOUN
biomedich-767	51	6	used	use	VERB
biomedich-767	51	7	the	the	DET
biomedich-767	51	8	hypothesis	hypothesis	NOUN
biomedich-767	51	9	test	test	NOUN
biomedich-767	51	10	of	of	ADP
biomedich-767	51	11	the	the	DET
biomedich-767	51	12	difference	difference	NOUN
biomedich-767	51	13	between	between	ADP
biomedich-767	51	14	two	two	NUM
biomedich-767	51	15	populations	population	NOUN
biomedich-767	51	16	for	for	ADP
biomedich-767	51	17	the	the	DET
biomedich-767	51	18	calculation	calculation	NOUN
biomedich-767	51	19	of	of	ADP
biomedich-767	51	20	sample	sample	NOUN
biomedich-767	51	21	size	size	NOUN
biomedich-767	51	22	with	with	ADP
biomedich-767	51	23	the	the	DET
biomedich-767	51	24	formula	formula	NOUN
biomedich-767	51	25	:	:	PUNCT
biomedich-767	51	26	the	the	DET
biomedich-767	51	27	medical	medical	ADJ
biomedich-767	51	28	record	record	NOUN
biomedich-767	51	29	data	datum	NOUN
biomedich-767	51	30	obtained	obtain	VERB
biomedich-767	51	31	provides	provide	VERB
biomedich-767	51	32	information	information	NOUN
biomedich-767	51	33	about	about	ADP
biomedich-767	51	34	the	the	DET
biomedich-767	51	35	characteristics	characteristic	NOUN
biomedich-767	51	36	of	of	ADP
biomedich-767	51	37	the	the	DET
biomedich-767	51	38	patient	patient	NOUN
biomedich-767	51	39	(	(	PUNCT
biomedich-767	51	40	age	age	NOUN
biomedich-767	51	41	,	,	PUNCT
biomedich-767	51	42	sex	sex	NOUN
biomedich-767	51	43	,	,	PUNCT
biomedich-767	51	44	length	length	NOUN
biomedich-767	51	45	of	of	ADP
biomedich-767	51	46	treatment	treatment	NOUN
biomedich-767	51	47	days	day	NOUN
biomedich-767	51	48	,	,	PUNCT
biomedich-767	51	49	pcr	pcr	NOUN
biomedich-767	51	50	value	value	NOUN
biomedich-767	51	51	,	,	PUNCT
biomedich-767	51	52	drug	drug	NOUN
biomedich-767	51	53	name	name	NOUN
biomedich-767	51	54	,	,	PUNCT
biomedich-767	51	55	dosage	dosage	NOUN
biomedich-767	51	56	,	,	PUNCT
biomedich-767	51	57	and	and	CCONJ
biomedich-767	51	58	interval	interval	NOUN
biomedich-767	51	59	of	of	ADP
biomedich-767	51	60	administration	administration	NOUN
biomedich-767	51	61	)	)	PUNCT
biomedich-767	51	62	.	.	PUNCT
biomedich-767	52	1	cost	cost	NOUN
biomedich-767	52	2	data	datum	NOUN
biomedich-767	52	3	consists	consist	VERB
biomedich-767	52	4	of	of	ADP
biomedich-767	52	5	direct	direct	ADJ
biomedich-767	52	6	costs	cost	NOUN
biomedich-767	52	7	obtained	obtain	VERB
biomedich-767	52	8	from	from	ADP
biomedich-767	52	9	financial	financial	ADJ
biomedich-767	52	10	documents	document	NOUN
biomedich-767	52	11	,	,	PUNCT
biomedich-767	52	12	which	which	PRON
biomedich-767	52	13	include	include	VERB
biomedich-767	52	14	drug	drug	NOUN
biomedich-767	52	15	costs	cost	NOUN
biomedich-767	52	16	,	,	PUNCT
biomedich-767	52	17	laboratory	laboratory	NOUN
biomedich-767	52	18	costs	cost	NOUN
biomedich-767	52	19	,	,	PUNCT
biomedich-767	52	20	doctor	doctor	NOUN
biomedich-767	52	21	consultation	consultation	NOUN
biomedich-767	52	22	fees	fee	NOUN
biomedich-767	52	23	,	,	PUNCT
biomedich-767	52	24	and	and	CCONJ
biomedich-767	52	25	administrative	administrative	ADJ
biomedich-767	52	26	costs	cost	NOUN
biomedich-767	52	27	.	.	PUNCT
biomedich-767	53	1	statistical	statistical	ADJ
biomedich-767	53	2	data	datum	NOUN
biomedich-767	53	3	analysis	analysis	NOUN
biomedich-767	53	4	using	use	VERB
biomedich-767	53	5	the	the	DET
biomedich-767	53	6	mann	mann	PROPN
biomedich-767	53	7	-	-	PUNCT
biomedich-767	53	8	whitney	whitney	PROPN
biomedich-767	53	9	method	method	NOUN
biomedich-767	53	10	was	be	AUX
biomedich-767	53	11	used	use	VERB
biomedich-767	53	12	to	to	PART
biomedich-767	53	13	compare	compare	VERB
biomedich-767	53	14	the	the	DET
biomedich-767	53	15	statistical	statistical	ADJ
biomedich-767	53	16	significance	significance	NOUN
biomedich-767	53	17	of	of	ADP
biomedich-767	53	18	variability	variability	NOUN
biomedich-767	53	19	(	(	PUNCT
biomedich-767	53	20	see	see	VERB
biomedich-767	53	21	meaningful	meaningful	ADJ
biomedich-767	53	22	differences	difference	NOUN
biomedich-767	53	23	between	between	ADP
biomedich-767	53	24	kedua	kedua	PROPN
biomedich-767	53	25	antiretroviral	antiretroviral	ADJ
biomedich-767	53	26	favipiravir	favipiravir	NOUN
biomedich-767	53	27	and	and	CCONJ
biomedich-767	53	28	oseltamivir	oseltamivir	PROPN
biomedich-767	53	29	)	)	PUNCT
biomedich-767	53	30	.	.	PUNCT
biomedich-767	54	1	pharmacoeconomic	pharmacoeconomic	ADJ
biomedich-767	54	2	analysis	analysis	NOUN
biomedich-767	54	3	,	,	PUNCT
biomedich-767	54	4	the	the	DET
biomedich-767	54	5	average	average	ADJ
biomedich-767	54	6	costeffectiveness	costeffectiveness	NOUN
biomedich-767	54	7	ratio	ratio	NOUN
biomedich-767	54	8	(	(	PUNCT
biomedich-767	54	9	acer	acer	NOUN
biomedich-767	54	10	)	)	PUNCT
biomedich-767	54	11	is	be	AUX
biomedich-767	54	12	the	the	DET
biomedich-767	54	13	total	total	ADJ
biomedich-767	54	14	cost	cost	NOUN
biomedich-767	54	15	divided	divide	VERB
biomedich-767	54	16	by	by	ADP
biomedich-767	54	17	the	the	DET
biomedich-767	54	18	output	output	NOUN
biomedich-767	54	19	or	or	CCONJ
biomedich-767	54	20	effectiveness	effectiveness	NOUN
biomedich-767	54	21	of	of	ADP
biomedich-767	54	22	each	each	DET
biomedich-767	54	23	method	method	NOUN
biomedich-767	54	24	.	.	PUNCT
biomedich-767	55	1	the	the	DET
biomedich-767	55	2	acer	acer	NOUN
biomedich-767	55	3	generated	generate	VERB
biomedich-767	55	4	by	by	ADP
biomedich-767	55	5	each	each	DET
biomedich-767	55	6	method	method	NOUN
biomedich-767	55	7	is	be	AUX
biomedich-767	55	8	then	then	ADV
biomedich-767	55	9	compared	compare	VERB
biomedich-767	55	10	;	;	PUNCT
biomedich-767	55	11	smaller	small	ADJ
biomedich-767	55	12	values	value	NOUN
biomedich-767	55	13	indicate	indicate	VERB
biomedich-767	55	14	a	a	DET
biomedich-767	55	15	more	more	ADV
biomedich-767	55	16	costeffective	costeffective	ADJ
biomedich-767	55	17	method	method	NOUN
biomedich-767	55	18	compared	compare	VERB
biomedich-767	55	19	to	to	ADP
biomedich-767	55	20	other	other	ADJ
biomedich-767	55	21	methods	method	NOUN
biomedich-767	55	22	.	.	PUNCT
biomedich-767	56	1	grids	grid	NOUN
biomedich-767	56	2	are	be	AUX
biomedich-767	56	3	used	use	VERB
biomedich-767	56	4	to	to	PART
biomedich-767	56	5	describe	describe	VERB
biomedich-767	56	6	the	the	DET
biomedich-767	56	7	cost	cost	NOUN
biomedich-767	56	8	position	position	NOUN
biomedich-767	56	9	and	and	CCONJ
biomedich-767	56	10	outcome	outcome	NOUN
biomedich-767	56	11	of	of	ADP
biomedich-767	56	12	alternative	alternative	ADJ
biomedich-767	56	13	interventions	intervention	NOUN
biomedich-767	56	14	.	.	PUNCT
biomedich-767	57	1	research	research	NOUN
biomedich-767	57	2	ethics	ethic	NOUN
biomedich-767	57	3	committee	committee	PROPN
biomedich-767	57	4	of	of	ADP
biomedich-767	57	5	stikes	stikes	PROPN
biomedich-767	57	6	prima	prima	PROPN
biomedich-767	57	7	indonesia	indonesia	PROPN
biomedich-767	57	8	,	,	PUNCT
biomedich-767	57	9	no	no	INTJ
biomedich-767	57	10	.	.	NOUN
biomedich-767	57	11	206	206	NUM
biomedich-767	57	12	/	/	SYM
biomedich-767	57	13	ec	ec	PROPN
biomedich-767	57	14	/	/	SYM
biomedich-767	57	15	kepk	kepk	ADJ
biomedich-767	57	16	stikes	stikes	PROPN
biomedich-767	57	17	-	-	PUNCT
biomedich-767	57	18	pi	pi	NOUN
biomedich-767	57	19	/	/	SYM
biomedich-767	57	20	viii/2022	viii/2022	NOUN
biomedich-767	57	21	has	have	AUX
biomedich-767	57	22	provided	provide	VERB
biomedich-767	57	23	information	information	NOUN
biomedich-767	57	24	that	that	PRON
biomedich-767	57	25	passed	pass	VERB
biomedich-767	57	26	the	the	DET
biomedich-767	57	27	ethical	ethical	ADJ
biomedich-767	57	28	review	review	NOUN
biomedich-767	57	29	for	for	ADP
biomedich-767	57	30	this	this	DET
biomedich-767	57	31	study	study	NOUN
biomedich-767	57	32	.	.	PUNCT
biomedich-767	58	1	rahayu	rahayu	PROPN
biomedich-767	58	2	et	et	PROPN
biomedich-767	58	3	al	al	PROPN
biomedich-767	58	4	.	.	PROPN
biomedich-767	58	5	–	–	PUNCT
biomedich-767	58	6	cost	cost	NOUN
biomedich-767	58	7	effectiveness	effectiveness	NOUN
biomedich-767	58	8	analysis	analysis	NOUN
biomedich-767	58	9	of	of	ADP
biomedich-767	58	10	favipiravir	favipiravir	NOUN
biomedich-767	58	11	and	and	CCONJ
biomedich-767	58	12	oseltamivir	oseltamivir	NOUN
biomedich-767	58	13	as	as	ADP
biomedich-767	58	14	…	…	PUNCT
biomedich-767	58	15	1221	1221	NUM
biomedich-767	58	16	results	result	NOUN
biomedich-767	58	17	and	and	CCONJ
biomedich-767	58	18	discussion	discussion	NOUN
biomedich-767	58	19	characteristics	characteristic	NOUN
biomedich-767	58	20	of	of	ADP
biomedich-767	58	21	research	research	NOUN
biomedich-767	58	22	subjects	subject	NOUN
biomedich-767	58	23	table	table	VERB
biomedich-767	58	24	1	1	NUM
biomedich-767	58	25	.	.	PUNCT
biomedich-767	59	1	characteristics	characteristic	NOUN
biomedich-767	59	2	of	of	ADP
biomedich-767	59	3	covid	covid	PROPN
biomedich-767	59	4	19	19	NUM
biomedich-767	59	5	patients	patient	NOUN
biomedich-767	59	6	.	.	PUNCT
biomedich-767	60	1	no	no	DET
biomedich-767	60	2	variable	variable	ADJ
biomedich-767	60	3	category	category	NOUN
biomedich-767	60	4	favipiravir	favipiravir	VERB
biomedich-767	60	5	n=	n=	ADJ
biomedich-767	60	6	40	40	NUM
biomedich-767	60	7	oseltamivir	oseltamivir	PROPN
biomedich-767	60	8	n=40	n=40	ADJ
biomedich-767	60	9	total	total	ADJ
biomedich-767	60	10	n=80	n=80	ADJ
biomedich-767	60	11	1	1	NUM
biomedich-767	60	12	gender	gender	NOUN
biomedich-767	60	13	man	man	NOUN
biomedich-767	60	14	24	24	NUM
biomedich-767	60	15	25	25	NUM
biomedich-767	60	16	49	49	NUM
biomedich-767	60	17	women	woman	NOUN
biomedich-767	60	18	16	16	NUM
biomedich-767	60	19	15	15	NUM
biomedich-767	60	20	31	31	NUM
biomedich-767	60	21	2	2	NUM
biomedich-767	60	22	place	place	NOUN
biomedich-767	60	23	of	of	ADP
biomedich-767	60	24	residence	residence	NOUN
biomedich-767	60	25	bogor	bogor	PROPN
biomedich-767	60	26	regency	regency	PROPN
biomedich-767	60	27	23	23	NUM
biomedich-767	60	28	25	25	NUM
biomedich-767	60	29	48	48	NUM
biomedich-767	60	30	bogor	bogor	NOUN
biomedich-767	60	31	city	city	NOUN
biomedich-767	60	32	4	4	NUM
biomedich-767	60	33	7	7	NUM
biomedich-767	60	34	11	11	NUM
biomedich-767	60	35	outside	outside	ADP
biomedich-767	60	36	bogor	bogor	NOUN
biomedich-767	60	37	13	13	NUM
biomedich-767	60	38	8	8	NUM
biomedich-767	60	39	21	21	NUM
biomedich-767	60	40	3	3	NUM
biomedich-767	60	41	length	length	NOUN
biomedich-767	60	42	of	of	ADP
biomedich-767	60	43	days	day	NOUN
biomedich-767	60	44	1	1	NUM
biomedich-767	60	45	8	8	NUM
biomedich-767	60	46	37	37	NUM
biomedich-767	60	47	21	21	NUM
biomedich-767	60	48	58	58	NUM
biomedich-767	60	49	therapy	therapy	NOUN
biomedich-767	60	50	9	9	NUM
biomedich-767	60	51	16	16	NUM
biomedich-767	60	52	3	3	NUM
biomedich-767	60	53	13	13	NUM
biomedich-767	60	54	16	16	NUM
biomedich-767	60	55	17	17	NUM
biomedich-767	60	56	24	24	NUM
biomedich-767	60	57	0	0	NUM
biomedich-767	60	58	6	6	NUM
biomedich-767	60	59	6	6	NUM
biomedich-767	60	60	4	4	NUM
biomedich-767	60	61	pcr	pcr	NOUN
biomedich-767	60	62	results	result	NOUN
biomedich-767	60	63	positif	positif	VERB
biomedich-767	60	64	30	30	NUM
biomedich-767	60	65	39	39	NUM
biomedich-767	60	66	74	74	NUM
biomedich-767	60	67	rs	rs	NOUN
biomedich-767	60	68	exit	exit	NOUN
biomedich-767	60	69	negatif	negatif	NOUN
biomedich-767	60	70	10	10	NUM
biomedich-767	60	71	1	1	NUM
biomedich-767	60	72	6	6	NUM
biomedich-767	60	73	the	the	DET
biomedich-767	60	74	study	study	NOUN
biomedich-767	60	75	conducted	conduct	VERB
biomedich-767	60	76	in	in	ADP
biomedich-767	60	77	the	the	DET
biomedich-767	60	78	covid-19	covid-19	PROPN
biomedich-767	60	79	treatment	treatment	NOUN
biomedich-767	60	80	room	room	NOUN
biomedich-767	60	81	of	of	ADP
biomedich-767	60	82	cisarua	cisarua	PROPN
biomedich-767	60	83	bogor	bogor	PROPN
biomedich-767	60	84	lung	lung	PROPN
biomedich-767	60	85	hospital	hospital	NOUN
biomedich-767	60	86	during	during	ADP
biomedich-767	60	87	a	a	DET
biomedich-767	60	88	period	period	NOUN
biomedich-767	60	89	of	of	ADP
biomedich-767	60	90	2	2	NUM
biomedich-767	60	91	months	month	NOUN
biomedich-767	60	92	(	(	PUNCT
biomedich-767	60	93	september	september	PROPN
biomedich-767	60	94	–	–	PUNCT
biomedich-767	60	95	october	october	PROPN
biomedich-767	60	96	2022	2022	NUM
biomedich-767	60	97	)	)	PUNCT
biomedich-767	60	98	,	,	PUNCT
biomedich-767	60	99	the	the	DET
biomedich-767	60	100	number	number	NOUN
biomedich-767	60	101	of	of	ADP
biomedich-767	60	102	hospitalized	hospitalize	VERB
biomedich-767	60	103	covid-19	covid-19	PROPN
biomedich-767	60	104	patients	patient	NOUN
biomedich-767	60	105	who	who	PRON
biomedich-767	60	106	met	meet	VERB
biomedich-767	60	107	the	the	DET
biomedich-767	60	108	inclusion	inclusion	NOUN
biomedich-767	60	109	criteria	criterion	NOUN
biomedich-767	60	110	and	and	CCONJ
biomedich-767	60	111	exclusion	exclusion	NOUN
biomedich-767	60	112	criteria	criterion	NOUN
biomedich-767	60	113	was	be	AUX
biomedich-767	60	114	80	80	NUM
biomedich-767	60	115	(	(	PUNCT
biomedich-767	60	116	research	research	NOUN
biomedich-767	60	117	sample	sample	NOUN
biomedich-767	60	118	)	)	PUNCT
biomedich-767	60	119	,	,	PUNCT
biomedich-767	60	120	consisting	consist	VERB
biomedich-767	60	121	of	of	ADP
biomedich-767	60	122	40	40	NUM
biomedich-767	60	123	patients	patient	NOUN
biomedich-767	60	124	who	who	PRON
biomedich-767	60	125	received	receive	VERB
biomedich-767	60	126	favipiravir	favipiravir	NOUN
biomedich-767	60	127	antiretroviral	antiretroviral	ADJ
biomedich-767	60	128	and	and	CCONJ
biomedich-767	60	129	40	40	NUM
biomedich-767	60	130	patients	patient	NOUN
biomedich-767	60	131	who	who	PRON
biomedich-767	60	132	received	receive	VERB
biomedich-767	60	133	oseltamivir	oseltamivir	NOUN
biomedich-767	61	1	antiretroviral	antiretroviral	ADJ
biomedich-767	61	2	.	.	PUNCT
biomedich-767	61	3	table	table	NOUN
biomedich-767	62	1	i	i	PRON
biomedich-767	62	2	shows	show	VERB
biomedich-767	62	3	the	the	DET
biomedich-767	62	4	characteristics	characteristic	NOUN
biomedich-767	62	5	of	of	ADP
biomedich-767	62	6	inpatient	inpatient	PROPN
biomedich-767	62	7	covid-19	covid-19	PROPN
biomedich-767	62	8	patients	patient	NOUN
biomedich-767	62	9	in	in	ADP
biomedich-767	62	10	cisarua	cisarua	PROPN
biomedich-767	62	11	bogor	bogor	PROPN
biomedich-767	62	12	lung	lung	PROPN
biomedich-767	62	13	hospital	hospital	NOUN
biomedich-767	62	14	for	for	ADP
biomedich-767	62	15	the	the	DET
biomedich-767	62	16	july	july	PROPN
biomedich-767	62	17	–	–	PUNCT
biomedich-767	62	18	december	december	PROPN
biomedich-767	62	19	2021	2021	NUM
biomedich-767	62	20	period	period	NOUN
biomedich-767	62	21	as	as	SCONJ
biomedich-767	62	22	follows	follow	VERB
biomedich-767	62	23	:	:	PUNCT
biomedich-767	62	24	for	for	ADP
biomedich-767	62	25	sex	sex	NOUN
biomedich-767	62	26	characteristics	characteristic	NOUN
biomedich-767	62	27	,	,	PUNCT
biomedich-767	62	28	the	the	DET
biomedich-767	62	29	80	80	NUM
biomedich-767	62	30	samples	sample	NOUN
biomedich-767	62	31	used	use	VERB
biomedich-767	62	32	showed	show	VERB
biomedich-767	62	33	that	that	SCONJ
biomedich-767	62	34	in	in	ADP
biomedich-767	62	35	favipiravir	favipiravir	PROPN
biomedich-767	62	36	antiretrovirals	antiretroviral	NOUN
biomedich-767	62	37	,	,	PUNCT
biomedich-767	62	38	male	male	ADJ
biomedich-767	62	39	sex	sex	NOUN
biomedich-767	62	40	is	be	AUX
biomedich-767	62	41	24	24	NUM
biomedich-767	62	42	%	%	NOUN
biomedich-767	62	43	and	and	CCONJ
biomedich-767	62	44	female	female	ADJ
biomedich-767	62	45	sex	sex	NOUN
biomedich-767	62	46	is	be	AUX
biomedich-767	62	47	16	16	NUM
biomedich-767	62	48	%	%	NOUN
biomedich-767	62	49	,	,	PUNCT
biomedich-767	62	50	while	while	SCONJ
biomedich-767	62	51	in	in	ADP
biomedich-767	62	52	oseltamivir	oseltamivir	PROPN
biomedich-767	62	53	antiretrovirals	antiretroviral	NOUN
biomedich-767	62	54	,	,	PUNCT
biomedich-767	62	55	male	male	ADJ
biomedich-767	62	56	sex	sex	NOUN
biomedich-767	62	57	is	be	AUX
biomedich-767	62	58	25	25	NUM
biomedich-767	62	59	%	%	NOUN
biomedich-767	62	60	and	and	CCONJ
biomedich-767	62	61	female	female	ADJ
biomedich-767	62	62	sex	sex	NOUN
biomedich-767	62	63	is	be	AUX
biomedich-767	62	64	15	15	NUM
biomedich-767	62	65	%	%	NOUN
biomedich-767	62	66	.	.	PUNCT
biomedich-767	63	1	this	this	PRON
biomedich-767	63	2	is	be	AUX
biomedich-767	63	3	because	because	SCONJ
biomedich-767	63	4	men	man	NOUN
biomedich-767	63	5	have	have	VERB
biomedich-767	63	6	higher	high	ADJ
biomedich-767	63	7	levels	level	NOUN
biomedich-767	63	8	of	of	ADP
biomedich-767	63	9	enzymes	enzyme	NOUN
biomedich-767	63	10	in	in	ADP
biomedich-767	63	11	the	the	DET
biomedich-767	63	12	blood	blood	NOUN
biomedich-767	63	13	than	than	ADP
biomedich-767	63	14	women	woman	NOUN
biomedich-767	63	15	.	.	PUNCT
biomedich-767	64	1	enzymes	enzyme	NOUN
biomedich-767	64	2	are	be	AUX
biomedich-767	64	3	a	a	DET
biomedich-767	64	4	key	key	ADJ
biomedich-767	64	5	factor	factor	NOUN
biomedich-767	64	6	for	for	SCONJ
biomedich-767	64	7	covid-19	covid-19	PROPN
biomedich-767	64	8	to	to	PART
biomedich-767	64	9	infect	infect	VERB
biomedich-767	64	10	human	human	ADJ
biomedich-767	64	11	cells	cell	NOUN
biomedich-767	64	12	(	(	PUNCT
biomedich-767	64	13	centers	center	NOUN
biomedich-767	64	14	for	for	ADP
biomedich-767	64	15	disease	disease	NOUN
biomedich-767	64	16	control	control	NOUN
biomedich-767	64	17	and	and	CCONJ
biomedich-767	64	18	prevention	prevention	NOUN
biomedich-767	64	19	,	,	PUNCT
biomedich-767	64	20	2020	2020	NUM
biomedich-767	64	21	(	(	PUNCT
biomedich-767	64	22	9	9	NUM
biomedich-767	64	23	,	,	PUNCT
biomedich-767	64	24	10	10	NUM
biomedich-767	64	25	)	)	PUNCT
biomedich-767	64	26	.	.	PUNCT
biomedich-767	65	1	for	for	ADP
biomedich-767	65	2	patient	patient	ADJ
biomedich-767	65	3	residences	residence	NOUN
biomedich-767	65	4	,	,	PUNCT
biomedich-767	65	5	the	the	DET
biomedich-767	65	6	80	80	NUM
biomedich-767	65	7	samples	sample	NOUN
biomedich-767	65	8	used	use	VERB
biomedich-767	65	9	showed	show	VERB
biomedich-767	65	10	that	that	SCONJ
biomedich-767	65	11	patients	patient	NOUN
biomedich-767	65	12	living	live	VERB
biomedich-767	65	13	in	in	ADP
biomedich-767	65	14	bogor	bogor	PROPN
biomedich-767	65	15	regency	regency	NOUN
biomedich-767	65	16	by	by	ADP
biomedich-767	65	17	48	48	NUM
biomedich-767	65	18	%	%	NOUN
biomedich-767	65	19	,	,	PUNCT
biomedich-767	65	20	bogor	bogor	PROPN
biomedich-767	65	21	city	city	NOUN
biomedich-767	65	22	by	by	ADP
biomedich-767	65	23	11	11	NUM
biomedich-767	65	24	%	%	NOUN
biomedich-767	65	25	,	,	PUNCT
biomedich-767	65	26	and	and	CCONJ
biomedich-767	65	27	outside	outside	ADJ
biomedich-767	65	28	bogor	bogor	NOUN
biomedich-767	65	29	by	by	ADP
biomedich-767	65	30	21	21	NUM
biomedich-767	65	31	%	%	NOUN
biomedich-767	65	32	showed	show	VERB
biomedich-767	65	33	that	that	SCONJ
biomedich-767	65	34	there	there	PRON
biomedich-767	65	35	were	be	VERB
biomedich-767	65	36	patients	patient	NOUN
biomedich-767	65	37	living	live	VERB
biomedich-767	65	38	in	in	ADP
biomedich-767	65	39	bogor	bogor	NOUN
biomedich-767	65	40	city	city	NOUN
biomedich-767	65	41	because	because	SCONJ
biomedich-767	65	42	of	of	ADP
biomedich-767	65	43	the	the	DET
biomedich-767	65	44	hospital	hospital	NOUN
biomedich-767	65	45	.	.	PUNCT
biomedich-767	66	1	cisarua	cisarua	PROPN
biomedich-767	66	2	bogor	bogor	PROPN
biomedich-767	66	3	lung	lung	PROPN
biomedich-767	66	4	hospital	hospital	NOUN
biomedich-767	66	5	is	be	AUX
biomedich-767	66	6	a	a	DET
biomedich-767	66	7	government	government	NOUN
biomedich-767	66	8	referral	referral	ADJ
biomedich-767	66	9	hospital	hospital	NOUN
biomedich-767	66	10	for	for	ADP
biomedich-767	66	11	treatment	treatment	NOUN
biomedich-767	66	12	.	.	PUNCT
biomedich-767	67	1	covid-19	covid-19	PROPN
biomedich-767	67	2	.	.	PROPN
biomedich-767	67	3	length	length	NOUN
biomedich-767	67	4	of	of	ADP
biomedich-767	67	5	stay	stay	NOUN
biomedich-767	67	6	(	(	PUNCT
biomedich-767	67	7	los	los	PROPN
biomedich-767	67	8	)	)	PUNCT
biomedich-767	67	9	is	be	AUX
biomedich-767	67	10	a	a	DET
biomedich-767	67	11	duration	duration	NOUN
biomedich-767	67	12	of	of	ADP
biomedich-767	67	13	treatment	treatment	NOUN
biomedich-767	67	14	of	of	ADP
biomedich-767	67	15	a	a	DET
biomedich-767	67	16	patient	patient	NOUN
biomedich-767	67	17	in	in	ADP
biomedich-767	67	18	a	a	DET
biomedich-767	67	19	health	health	NOUN
biomedich-767	67	20	facility	facility	NOUN
biomedich-767	67	21	.	.	PUNCT
biomedich-767	68	1	los	los	PROPN
biomedich-767	68	2	is	be	AUX
biomedich-767	68	3	one	one	NUM
biomedich-767	68	4	of	of	ADP
biomedich-767	68	5	the	the	DET
biomedich-767	68	6	factors	factor	NOUN
biomedich-767	68	7	that	that	PRON
biomedich-767	68	8	affect	affect	VERB
biomedich-767	68	9	the	the	DET
biomedich-767	68	10	health	health	NOUN
biomedich-767	68	11	care	care	NOUN
biomedich-767	68	12	system	system	NOUN
biomedich-767	68	13	and	and	CCONJ
biomedich-767	68	14	shows	show	VERB
biomedich-767	68	15	that	that	SCONJ
biomedich-767	68	16	the	the	PRON
biomedich-767	68	17	longer	long	ADJ
biomedich-767	68	18	a	a	DET
biomedich-767	68	19	patient	patient	NOUN
biomedich-767	68	20	's	's	PART
biomedich-767	68	21	stay	stay	NOUN
biomedich-767	68	22	in	in	ADP
biomedich-767	68	23	the	the	DET
biomedich-767	68	24	hospital	hospital	NOUN
biomedich-767	68	25	,	,	PUNCT
biomedich-767	68	26	the	the	PRON
biomedich-767	68	27	greater	great	ADJ
biomedich-767	68	28	the	the	DET
biomedich-767	68	29	patient	patient	NOUN
biomedich-767	68	30	's	's	PART
biomedich-767	68	31	need	need	NOUN
biomedich-767	68	32	for	for	ADP
biomedich-767	68	33	resources	resource	NOUN
biomedich-767	68	34	,	,	PUNCT
biomedich-767	68	35	including	include	VERB
biomedich-767	68	36	medical	medical	ADJ
biomedich-767	68	37	personnel	personnel	NOUN
biomedich-767	68	38	,	,	PUNCT
biomedich-767	68	39	materials	material	NOUN
biomedich-767	68	40	,	,	PUNCT
biomedich-767	68	41	drugs	drug	NOUN
biomedich-767	68	42	,	,	PUNCT
biomedich-767	68	43	and	and	CCONJ
biomedich-767	68	44	equipment	equipment	NOUN
biomedich-767	68	45	,	,	PUNCT
biomedich-767	68	46	resulting	result	VERB
biomedich-767	68	47	in	in	ADP
biomedich-767	68	48	increased	increase	VERB
biomedich-767	68	49	costs	cost	NOUN
biomedich-767	68	50	therapy	therapy	NOUN
biomedich-767	68	51	.	.	PUNCT
biomedich-767	69	1	the	the	DET
biomedich-767	69	2	length	length	NOUN
biomedich-767	69	3	of	of	ADP
biomedich-767	69	4	treatment	treatment	NOUN
biomedich-767	69	5	days	day	NOUN
biomedich-767	69	6	for	for	ADP
biomedich-767	69	7	patients	patient	NOUN
biomedich-767	69	8	taking	take	VERB
biomedich-767	69	9	favipiravir	favipiravir	PROPN
biomedich-767	69	10	antiretrovirals	antiretroviral	NOUN
biomedich-767	69	11	1	1	NUM
biomedich-767	69	12	-	-	SYM
biomedich-767	69	13	8	8	NUM
biomedich-767	69	14	days	day	NOUN
biomedich-767	69	15	treatment	treatment	NOUN
biomedich-767	69	16	period	period	NOUN
biomedich-767	69	17	is	be	AUX
biomedich-767	69	18	37	37	NUM
biomedich-767	69	19	%	%	NOUN
biomedich-767	69	20	,	,	PUNCT
biomedich-767	69	21	9	9	NUM
biomedich-767	69	22	-	-	SYM
biomedich-767	69	23	16	16	NUM
biomedich-767	69	24	days	day	NOUN
biomedich-767	69	25	is	be	AUX
biomedich-767	69	26	3	3	NUM
biomedich-767	69	27	%	%	NOUN
biomedich-767	69	28	,	,	PUNCT
biomedich-767	69	29	and	and	CCONJ
biomedich-767	69	30	there	there	PRON
biomedich-767	69	31	are	be	VERB
biomedich-767	69	32	no	no	DET
biomedich-767	69	33	patients	patient	NOUN
biomedich-767	69	34	with	with	ADP
biomedich-767	69	35	17	17	NUM
biomedich-767	69	36	-	-	SYM
biomedich-767	69	37	24	24	NUM
biomedich-767	69	38	days	day	NOUN
biomedich-767	69	39	of	of	ADP
biomedich-767	69	40	treatment	treatment	NOUN
biomedich-767	69	41	,	,	PUNCT
biomedich-767	69	42	while	while	SCONJ
biomedich-767	69	43	in	in	ADP
biomedich-767	69	44	oseltamivir	oseltamivir	PROPN
biomedich-767	69	45	antiretrovirals	antiretroviral	NOUN
biomedich-767	69	46	the	the	DET
biomedich-767	69	47	treatment	treatment	NOUN
biomedich-767	69	48	period	period	NOUN
biomedich-767	69	49	is	be	AUX
biomedich-767	69	50	1	1	NUM
biomedich-767	69	51	-	-	SYM
biomedich-767	69	52	8	8	NUM
biomedich-767	69	53	days	day	NOUN
biomedich-767	69	54	by	by	ADP
biomedich-767	69	55	21	21	NUM
biomedich-767	69	56	%	%	NOUN
biomedich-767	69	57	,	,	PUNCT
biomedich-767	69	58	9	9	NUM
biomedich-767	69	59	-	-	SYM
biomedich-767	69	60	16	16	NUM
biomedich-767	69	61	days	day	NOUN
biomedich-767	69	62	by	by	ADP
biomedich-767	69	63	13	13	NUM
biomedich-767	69	64	%	%	NOUN
biomedich-767	69	65	,	,	PUNCT
biomedich-767	69	66	and	and	CCONJ
biomedich-767	69	67	17	17	NUM
biomedich-767	69	68	-	-	SYM
biomedich-767	69	69	24	24	NUM
biomedich-767	69	70	days	day	NOUN
biomedich-767	69	71	by	by	ADP
biomedich-767	69	72	6	6	NUM
biomedich-767	69	73	%	%	NOUN
biomedich-767	69	74	.	.	PUNCT
biomedich-767	70	1	this	this	PRON
biomedich-767	70	2	is	be	AUX
biomedich-767	70	3	in	in	ADP
biomedich-767	70	4	accordance	accordance	NOUN
biomedich-767	70	5	with	with	ADP
biomedich-767	70	6	research	research	NOUN
biomedich-767	70	7	conducted	conduct	VERB
biomedich-767	70	8	in	in	ADP
biomedich-767	70	9	china	china	PROPN
biomedich-767	70	10	,	,	PUNCT
biomedich-767	70	11	which	which	PRON
biomedich-767	70	12	shows	show	VERB
biomedich-767	70	13	that	that	SCONJ
biomedich-767	70	14	the	the	DET
biomedich-767	70	15	length	length	NOUN
biomedich-767	70	16	of	of	ADP
biomedich-767	70	17	days	day	NOUN
biomedich-767	70	18	of	of	ADP
biomedich-767	70	19	treatment	treatment	NOUN
biomedich-767	70	20	for	for	ADP
biomedich-767	70	21	covid	covid	NOUN
biomedich-767	70	22	-	-	PUNCT
biomedich-767	70	23	patients	patient	NOUN
biomedich-767	70	24	19	19	NUM
biomedich-767	70	25	ranged	range	VERB
biomedich-767	70	26	from	from	ADP
biomedich-767	70	27	4	4	NUM
biomedich-767	70	28	to	to	PART
biomedich-767	70	29	53	53	NUM
biomedich-767	70	30	days	day	NOUN
biomedich-767	70	31	,	,	PUNCT
biomedich-767	70	32	and	and	CCONJ
biomedich-767	70	33	patients	patient	NOUN
biomedich-767	70	34	in	in	ADP
biomedich-767	70	35	the	the	DET
biomedich-767	70	36	icu	icu	PROPN
biomedich-767	70	37	ranged	range	VERB
biomedich-767	70	38	from	from	ADP
biomedich-767	70	39	6	6	NUM
biomedich-767	70	40	to	to	PART
biomedich-767	70	41	12	12	NUM
biomedich-767	70	42	days	day	NOUN
biomedich-767	70	43	(	(	PUNCT
biomedich-767	70	44	song	song	NOUN
biomedich-767	70	45	y	y	PROPN
biomedich-767	70	46	et	et	PROPN
biomedich-767	70	47	al	al	PROPN
biomedich-767	70	48	.	.	PROPN
biomedich-767	70	49	2020	2020	NUM
biomedich-767	70	50	,	,	PUNCT
biomedich-767	70	51	rees	ree	VERB
biomedich-767	70	52	em	em	PRON
biomedich-767	70	53	et	et	PROPN
biomedich-767	70	54	al	al	PROPN
biomedich-767	70	55	.	.	PROPN
biomedich-767	70	56	2020	2020	NUM
biomedich-767	70	57	)	)	PUNCT
biomedich-767	70	58	.	.	PUNCT
biomedich-767	71	1	polymerase	polymerase	NOUN
biomedich-767	71	2	chain	chain	NOUN
biomedich-767	71	3	reaction	reaction	NOUN
biomedich-767	71	4	(	(	PUNCT
biomedich-767	71	5	pcr	pcr	NOUN
biomedich-767	71	6	)	)	PUNCT
biomedich-767	71	7	status	status	NOUN
biomedich-767	71	8	when	when	SCONJ
biomedich-767	71	9	patients	patient	NOUN
biomedich-767	71	10	are	be	AUX
biomedich-767	71	11	discharged	discharge	VERB
biomedich-767	71	12	from	from	ADP
biomedich-767	71	13	the	the	DET
biomedich-767	71	14	hospital	hospital	NOUN
biomedich-767	71	15	:	:	PUNCT
biomedich-767	71	16	for	for	ADP
biomedich-767	71	17	patients	patient	NOUN
biomedich-767	71	18	using	use	VERB
biomedich-767	71	19	favipiravir	favipiravir	PROPN
biomedich-767	71	20	antiretrovirals	antiretroviral	NOUN
biomedich-767	71	21	,	,	PUNCT
biomedich-767	71	22	positive	positive	ADJ
biomedich-767	71	23	pcr	pcr	ADJ
biomedich-767	71	24	results	result	NOUN
biomedich-767	71	25	were	be	AUX
biomedich-767	71	26	30	30	NUM
biomedich-767	71	27	%	%	NOUN
biomedich-767	71	28	and	and	CCONJ
biomedich-767	71	29	negative	negative	ADJ
biomedich-767	71	30	pcr	pcr	NOUN
biomedich-767	71	31	was	be	AUX
biomedich-767	71	32	10	10	NUM
biomedich-767	71	33	%	%	NOUN
biomedich-767	71	34	;	;	PUNCT
biomedich-767	71	35	for	for	ADP
biomedich-767	71	36	patients	patient	NOUN
biomedich-767	71	37	using	use	VERB
biomedich-767	71	38	oseltamivir	oseltamivir	PROPN
biomedich-767	71	39	antiretrovirals	antiretroviral	NOUN
biomedich-767	71	40	,	,	PUNCT
biomedich-767	71	41	positive	positive	ADJ
biomedich-767	71	42	pcr	pcr	ADJ
biomedich-767	71	43	results	result	NOUN
biomedich-767	71	44	were	be	AUX
biomedich-767	71	45	39	39	NUM
biomedich-767	71	46	%	%	NOUN
biomedich-767	71	47	and	and	CCONJ
biomedich-767	71	48	negative	negative	ADJ
biomedich-767	71	49	pcr	pcr	NOUN
biomedich-767	71	50	was	be	AUX
biomedich-767	71	51	1	1	NUM
biomedich-767	71	52	%	%	NOUN
biomedich-767	71	53	(	(	PUNCT
biomedich-767	71	54	rees	ree	VERB
biomedich-767	71	55	em	em	PRON
biomedich-767	71	56	et	et	PROPN
biomedich-767	71	57	al	al	PROPN
biomedich-767	71	58	.	.	PROPN
biomedich-767	71	59	2020	2020	NUM
biomedich-767	71	60	,	,	PUNCT
biomedich-767	71	61	ye	ye	PRON
biomedich-767	71	62	q	q	PROPN
biomedich-767	71	63	,	,	PUNCT
biomedich-767	71	64	wang	wang	PROPN
biomedich-767	71	65	b	b	PROPN
biomedich-767	71	66	mj	mj	PROPN
biomedich-767	71	67	2020	2020	NUM
biomedich-767	71	68	)	)	PUNCT
biomedich-767	71	69	.	.	PUNCT
biomedich-767	72	1	when	when	SCONJ
biomedich-767	72	2	viewed	view	VERB
biomedich-767	72	3	from	from	ADP
biomedich-767	72	4	the	the	DET
biomedich-767	72	5	length	length	NOUN
biomedich-767	72	6	of	of	ADP
biomedich-767	72	7	treatment	treatment	NOUN
biomedich-767	72	8	days	day	NOUN
biomedich-767	72	9	with	with	ADP
biomedich-767	72	10	the	the	DET
biomedich-767	72	11	patient	patient	NOUN
biomedich-767	72	12	's	's	PART
biomedich-767	72	13	pcr	pcr	ADJ
biomedich-767	72	14	status	status	NOUN
biomedich-767	72	15	at	at	ADP
biomedich-767	72	16	the	the	DET
biomedich-767	72	17	time	time	NOUN
biomedich-767	72	18	of	of	ADP
biomedich-767	72	19	discharge	discharge	NOUN
biomedich-767	72	20	from	from	ADP
biomedich-767	72	21	the	the	DET
biomedich-767	72	22	hospital	hospital	NOUN
biomedich-767	72	23	,	,	PUNCT
biomedich-767	72	24	the	the	DET
biomedich-767	72	25	best	good	ADJ
biomedich-767	72	26	antiretroviral	antiretroviral	ADJ
biomedich-767	72	27	used	use	VERB
biomedich-767	72	28	for	for	ADP
biomedich-767	72	29	covid-19	covid-19	PROPN
biomedich-767	72	30	treatment	treatment	NOUN
biomedich-767	72	31	therapy	therapy	NOUN
biomedich-767	72	32	is	be	AUX
biomedich-767	72	33	favipiravir	favipiravir	PROPN
biomedich-767	72	34	,	,	PUNCT
biomedich-767	72	35	which	which	PRON
biomedich-767	72	36	is	be	AUX
biomedich-767	72	37	in	in	ADP
biomedich-767	72	38	accordance	accordance	NOUN
biomedich-767	72	39	with	with	ADP
biomedich-767	72	40	the	the	DET
biomedich-767	72	41	mechanism	mechanism	NOUN
biomedich-767	72	42	of	of	ADP
biomedich-767	72	43	action	action	NOUN
biomedich-767	72	44	.	.	PUNCT
biomedich-767	73	1	favipiravir	favipiravir	PROPN
biomedich-767	73	2	is	be	AUX
biomedich-767	73	3	a	a	DET
biomedich-767	73	4	type	type	NOUN
biomedich-767	73	5	of	of	ADP
biomedich-767	73	6	rna	rna	NOUN
biomedich-767	73	7	-	-	PUNCT
biomedich-767	73	8	dependent	dependent	ADJ
biomedich-767	73	9	rna	rna	NOUN
biomedich-767	73	10	polymerase	polymerase	NOUN
biomedich-767	73	11	(	(	PUNCT
biomedich-767	73	12	rdrp	rdrp	NOUN
biomedich-767	73	13	)	)	PUNCT
biomedich-767	73	14	inhibitor	inhibitor	NOUN
biomedich-767	73	15	(	(	PUNCT
biomedich-767	73	16	zhu	zhu	PROPN
biomedich-767	73	17	n.	n.	NOUN
biomedich-767	73	18	et	et	PROPN
biomedich-767	73	19	al	al	PROPN
biomedich-767	73	20	.	.	PROPN
biomedich-767	73	21	2020	2020	NUM
biomedich-767	73	22	)	)	PUNCT
biomedich-767	73	23	.	.	PUNCT
biomedich-767	74	1	on	on	ADP
biomedich-767	74	2	february	february	PROPN
biomedich-767	74	3	14	14	NUM
biomedich-767	74	4	,	,	PUNCT
biomedich-767	74	5	the	the	DET
biomedich-767	74	6	clinical	clinical	ADJ
biomedich-767	74	7	trial	trial	NOUN
biomedich-767	74	8	of	of	ADP
biomedich-767	74	9	favipiravir	favipiravir	NOUN
biomedich-767	74	10	for	for	ADP
biomedich-767	74	11	the	the	DET
biomedich-767	74	12	treatment	treatment	NOUN
biomedich-767	74	13	of	of	ADP
biomedich-767	74	14	covid-19	covid-19	PROPN
biomedich-767	74	15	was	be	AUX
biomedich-767	74	16	initiated	initiate	VERB
biomedich-767	74	17	by	by	ADP
biomedich-767	74	18	the	the	DET
biomedich-767	74	19	clinical	clinical	ADJ
biomedich-767	74	20	medical	medical	ADJ
biomedich-767	74	21	research	research	NOUN
biomedich-767	74	22	center	center	NOUN
biomedich-767	74	23	of	of	ADP
biomedich-767	74	24	the	the	DET
biomedich-767	74	25	third	third	ADJ
biomedich-767	74	26	people	people	NOUN
biomedich-767	74	27	's	's	PART
biomedich-767	74	28	hospital	hospital	NOUN
biomedich-767	74	29	of	of	ADP
biomedich-767	74	30	shenzhen	shenzhen	PROPN
biomedich-767	74	31	.	.	PUNCT
biomedich-767	75	1	baseline	baseline	PROPN
biomedich-767	75	2	results	result	NOUN
biomedich-767	75	3	from	from	ADP
biomedich-767	75	4	a	a	DET
biomedich-767	75	5	total	total	NOUN
biomedich-767	75	6	of	of	ADP
biomedich-767	75	7	80	80	NUM
biomedich-767	75	8	patients	patient	NOUN
biomedich-767	75	9	(	(	PUNCT
biomedich-767	75	10	including	include	VERB
biomedich-767	75	11	experimental	experimental	ADJ
biomedich-767	75	12	and	and	CCONJ
biomedich-767	75	13	control	control	NOUN
biomedich-767	75	14	groups	group	NOUN
biomedich-767	75	15	)	)	PUNCT
biomedich-767	75	16	showed	show	VERB
biomedich-767	75	17	that	that	SCONJ
biomedich-767	75	18	favipiravir	favipiravir	PROPN
biomedich-767	75	19	had	have	VERB
biomedich-767	75	20	a	a	DET
biomedich-767	75	21	stronger	strong	ADJ
biomedich-767	75	22	effect	effect	NOUN
biomedich-767	75	23	compared	compare	VERB
biomedich-767	75	24	to	to	ADP
biomedich-767	75	25	lopinavir	lopinavir	PROPN
biomedich-767	75	26	and	and	CCONJ
biomedich-767	75	27	ritonavir	ritonavir	PROPN
biomedich-767	75	28	.	.	PUNCT
biomedich-767	76	1	there	there	PRON
biomedich-767	76	2	were	be	VERB
biomedich-767	76	3	no	no	DET
biomedich-767	76	4	adverse	adverse	ADJ
biomedich-767	76	5	reactions	reaction	NOUN
biomedich-767	76	6	or	or	CCONJ
biomedich-767	76	7	significant	significant	ADJ
biomedich-767	76	8	side	side	NOUN
biomedich-767	76	9	effects	effect	NOUN
biomedich-767	76	10	in	in	ADP
biomedich-767	76	11	the	the	DET
biomedich-767	76	12	favipiravir	favipiravir	PROPN
biomedich-767	76	13	treatment	treatment	NOUN
biomedich-767	76	14	group	group	NOUN
biomedich-767	76	15	compared	compare	VERB
biomedich-767	76	16	to	to	ADP
biomedich-767	76	17	the	the	DET
biomedich-767	76	18	lopinavir	lopinavir	PROPN
biomedich-767	76	19	/	/	SYM
biomedich-767	76	20	ritonavir	ritonavir	PROPN
biomedich-767	76	21	group	group	NOUN
biomedich-767	76	22	(	(	PUNCT
biomedich-767	76	23	suresh	suresh	PROPN
biomedich-767	76	24	kumar	kumar	PROPN
biomedich-767	76	25	vc	vc	PROPN
biomedich-767	76	26	et	et	PROPN
biomedich-767	76	27	al	al	PROPN
biomedich-767	76	28	.	.	PROPN
biomedich-767	76	29	2020	2020	NUM
biomedich-767	76	30	)	)	PUNCT
biomedich-767	76	31	.	.	PUNCT
biomedich-767	77	1	for	for	SCONJ
biomedich-767	77	2	oseltamir	oseltamir	PROPN
biomedich-767	77	3	to	to	PART
biomedich-767	77	4	provide	provide	VERB
biomedich-767	77	5	less	less	ADJ
biomedich-767	77	6	than	than	ADP
biomedich-767	77	7	maximum	maximum	ADJ
biomedich-767	77	8	results	result	NOUN
biomedich-767	77	9	than	than	ADP
biomedich-767	77	10	favipiravir	favipiravir	NOUN
biomedich-767	77	11	,	,	PUNCT
biomedich-767	77	12	this	this	PRON
biomedich-767	77	13	is	be	AUX
biomedich-767	77	14	in	in	ADP
biomedich-767	77	15	line	line	NOUN
biomedich-767	77	16	with	with	ADP
biomedich-767	77	17	who	who	PRON
biomedich-767	77	18	's	be	AUX
biomedich-767	77	19	august	august	PROPN
biomedich-767	77	20	2022	2022	NUM
biomedich-767	77	21	revocation	revocation	NOUN
biomedich-767	77	22	of	of	ADP
biomedich-767	77	23	the	the	DET
biomedich-767	77	24	use	use	NOUN
biomedich-767	77	25	of	of	ADP
biomedich-767	77	26	oseltamivir	oseltamivir	NOUN
biomedich-767	77	27	for	for	ADP
biomedich-767	77	28	the	the	DET
biomedich-767	77	29	treatment	treatment	NOUN
biomedich-767	77	30	of	of	ADP
biomedich-767	77	31	covid19	covid19	NOUN
biomedich-767	77	32	.	.	PUNCT
biomedich-767	78	1	cost	cost	NOUN
biomedich-767	78	2	-	-	PUNCT
biomedich-767	78	3	effectiveness	effectiveness	NOUN
biomedich-767	78	4	analysis	analysis	NOUN
biomedich-767	78	5	is	be	AUX
biomedich-767	78	6	obtained	obtain	VERB
biomedich-767	78	7	by	by	ADP
biomedich-767	78	8	comparing	compare	VERB
biomedich-767	78	9	the	the	DET
biomedich-767	78	10	total	total	ADJ
biomedich-767	78	11	cost	cost	NOUN
biomedich-767	78	12	with	with	ADP
biomedich-767	78	13	the	the	DET
biomedich-767	78	14	effectiveness	effectiveness	NOUN
biomedich-767	78	15	of	of	ADP
biomedich-767	78	16	the	the	DET
biomedich-767	78	17	therapy	therapy	NOUN
biomedich-767	78	18	obtained	obtain	VERB
biomedich-767	78	19	(	(	PUNCT
biomedich-767	78	20	output	output	NOUN
biomedich-767	78	21	)	)	PUNCT
biomedich-767	78	22	.	.	PUNCT
biomedich-767	79	1	total	total	ADJ
biomedich-767	79	2	cost	cost	NOUN
biomedich-767	79	3	is	be	AUX
biomedich-767	79	4	a	a	DET
biomedich-767	79	5	combination	combination	NOUN
biomedich-767	79	6	of	of	ADP
biomedich-767	79	7	total	total	ADJ
biomedich-767	79	8	direct	direct	ADJ
biomedich-767	79	9	costs	cost	NOUN
biomedich-767	79	10	and	and	CCONJ
biomedich-767	79	11	indirect	indirect	ADJ
biomedich-767	79	12	costs	cost	NOUN
biomedich-767	79	13	.	.	PUNCT
biomedich-767	80	1	direct	direct	ADJ
biomedich-767	80	2	cost	cost	NOUN
biomedich-767	80	3	table	table	NOUN
biomedich-767	80	4	2	2	NUM
biomedich-767	80	5	.	.	PUNCT
biomedich-767	80	6	compares	compare	VERB
biomedich-767	80	7	the	the	DET
biomedich-767	80	8	cost	cost	NOUN
biomedich-767	80	9	-	-	PUNCT
biomedich-767	80	10	effectiveness	effectiveness	NOUN
biomedich-767	80	11	of	of	ADP
biomedich-767	80	12	antiretroviral	antiretroviral	ADJ
biomedich-767	80	13	administration	administration	NOUN
biomedich-767	80	14	.	.	PUNCT
biomedich-767	81	1	the	the	DET
biomedich-767	81	2	direct	direct	ADJ
biomedich-767	81	3	cost	cost	NOUN
biomedich-767	81	4	component	component	NOUN
biomedich-767	81	5	includes	include	VERB
biomedich-767	81	6	the	the	DET
biomedich-767	81	7	total	total	ADJ
biomedich-767	81	8	cost	cost	NOUN
biomedich-767	81	9	of	of	ADP
biomedich-767	81	10	treatment	treatment	NOUN
biomedich-767	81	11	(	(	PUNCT
biomedich-767	81	12	room	room	NOUN
biomedich-767	81	13	fee	fee	NOUN
biomedich-767	81	14	,	,	PUNCT
biomedich-767	81	15	drug	drug	NOUN
biomedich-767	81	16	fee	fee	NOUN
biomedich-767	81	17	,	,	PUNCT
biomedich-767	81	18	doctor	doctor	NOUN
biomedich-767	81	19	's	's	PART
biomedich-767	81	20	visit	visit	NOUN
biomedich-767	81	21	fee	fee	NOUN
biomedich-767	81	22	,	,	PUNCT
biomedich-767	81	23	and	and	CCONJ
biomedich-767	81	24	1222	1222	NUM
biomedich-767	81	25	biology	biology	NOUN
biomedich-767	81	26	,	,	PUNCT
biomedich-767	81	27	medicine	medicine	NOUN
biomedich-767	81	28	,	,	PUNCT
biomedich-767	81	29	&	&	CCONJ
biomedich-767	81	30	natural	natural	ADJ
biomedich-767	81	31	product	product	NOUN
biomedich-767	81	32	chemistry	chemistry	NOUN
biomedich-767	81	33	14	14	NUM
biomedich-767	81	34	(	(	PUNCT
biomedich-767	81	35	2	2	NUM
biomedich-767	81	36	)	)	PUNCT
biomedich-767	81	37	,	,	PUNCT
biomedich-767	81	38	2025	2025	NUM
biomedich-767	81	39	:	:	PUNCT
biomedich-767	81	40	1219	1219	NUM
biomedich-767	81	41	-	-	SYM
biomedich-767	81	42	1223	1223	NUM
biomedich-767	81	43	laboratory	laboratory	NOUN
biomedich-767	81	44	fee	fee	NOUN
biomedich-767	81	45	)	)	PUNCT
biomedich-767	81	46	.	.	PUNCT
biomedich-767	82	1	in	in	ADP
biomedich-767	82	2	table	table	NOUN
biomedich-767	82	3	2	2	NUM
biomedich-767	82	4	,	,	PUNCT
biomedich-767	82	5	the	the	DET
biomedich-767	82	6	results	result	NOUN
biomedich-767	82	7	of	of	ADP
biomedich-767	82	8	the	the	DET
biomedich-767	82	9	comparison	comparison	NOUN
biomedich-767	82	10	of	of	ADP
biomedich-767	82	11	cost	cost	NOUN
biomedich-767	82	12	-	-	PUNCT
biomedich-767	82	13	effectiveness	effectiveness	NOUN
biomedich-767	82	14	in	in	ADP
biomedich-767	82	15	the	the	DET
biomedich-767	82	16	administration	administration	NOUN
biomedich-767	82	17	of	of	ADP
biomedich-767	82	18	antiretrovirals	antiretroviral	NOUN
biomedich-767	82	19	favipiravir	favipiravir	NOUN
biomedich-767	82	20	and	and	CCONJ
biomedich-767	82	21	oseltamivir	oseltamivir	PROPN
biomedich-767	82	22	are	be	AUX
biomedich-767	82	23	as	as	SCONJ
biomedich-767	82	24	follows	follow	VERB
biomedich-767	82	25	:	:	PUNCT
biomedich-767	82	26	in	in	ADP
biomedich-767	82	27	patients	patient	NOUN
biomedich-767	82	28	using	use	VERB
biomedich-767	82	29	favipiravir	favipiravir	PROPN
biomedich-767	82	30	,	,	PUNCT
biomedich-767	82	31	the	the	DET
biomedich-767	82	32	average	average	ADJ
biomedich-767	82	33	total	total	ADJ
biomedich-767	82	34	cost	cost	NOUN
biomedich-767	82	35	is	be	AUX
biomedich-767	82	36	rp	rp	NOUN
biomedich-767	82	37	.	.	PROPN
biomedich-767	82	38	9,930,327	9,930,327	NUM
biomedich-767	82	39	per	per	ADP
biomedich-767	82	40	patient	patient	NOUN
biomedich-767	82	41	,	,	PUNCT
biomedich-767	82	42	while	while	SCONJ
biomedich-767	82	43	in	in	ADP
biomedich-767	82	44	patients	patient	NOUN
biomedich-767	82	45	using	use	VERB
biomedich-767	82	46	oseltamivir	oseltamivir	PROPN
biomedich-767	82	47	,	,	PUNCT
biomedich-767	82	48	the	the	DET
biomedich-767	82	49	average	average	ADJ
biomedich-767	82	50	length	length	NOUN
biomedich-767	82	51	of	of	ADP
biomedich-767	82	52	treatment	treatment	NOUN
biomedich-767	82	53	days	day	NOUN
biomedich-767	82	54	is	be	AUX
biomedich-767	82	55	rp	rp	NOUN
biomedich-767	82	56	.	.	PROPN
biomedich-767	82	57	12,368,397	12,368,397	NUM
biomedich-767	82	58	per	per	ADP
biomedich-767	82	59	patient	patient	NOUN
biomedich-767	82	60	.	.	PUNCT
biomedich-767	83	1	cost	cost	NOUN
biomedich-767	83	2	-	-	PUNCT
biomedich-767	83	3	effectiveness	effectiveness	NOUN
biomedich-767	83	4	analysis	analysis	NOUN
biomedich-767	83	5	figure	figure	NOUN
biomedich-767	83	6	1	1	NUM
biomedich-767	83	7	.	.	PUNCT
biomedich-767	83	8	alternative	alternative	PROPN
biomedich-767	83	9	group	group	NOUN
biomedich-767	83	10	based	base	VERB
biomedich-767	83	11	on	on	ADP
biomedich-767	83	12	total	total	ADJ
biomedich-767	83	13	cost	cost	NOUN
biomedich-767	83	14	-	-	PUNCT
biomedich-767	83	15	effectiveness	effectiveness	NOUN
biomedich-767	83	16	of	of	ADP
biomedich-767	83	17	antiretroviral	antiretroviral	ADJ
biomedich-767	83	18	administration	administration	NOUN
biomedich-767	83	19	.	.	PUNCT
biomedich-767	84	1	cost	cost	NOUN
biomedich-767	84	2	-	-	PUNCT
biomedich-767	84	3	effectiveness	effectiveness	NOUN
biomedich-767	84	4	analysis	analysis	NOUN
biomedich-767	84	5	is	be	AUX
biomedich-767	84	6	carried	carry	VERB
biomedich-767	84	7	out	out	ADP
biomedich-767	84	8	using	use	VERB
biomedich-767	84	9	the	the	DET
biomedich-767	84	10	average	average	ADJ
biomedich-767	84	11	cost	cost	NOUN
biomedich-767	84	12	effectiveness	effectiveness	NOUN
biomedich-767	84	13	ratio	ratio	NOUN
biomedich-767	84	14	(	(	PUNCT
biomedich-767	84	15	acer	acer	NOUN
biomedich-767	84	16	)	)	PUNCT
biomedich-767	84	17	and	and	CCONJ
biomedich-767	84	18	costeffectiveness	costeffectiveness	NOUN
biomedich-767	84	19	grid	grid	NOUN
biomedich-767	84	20	formulas	formula	NOUN
biomedich-767	84	21	.	.	PUNCT
biomedich-767	85	1	in	in	ADP
biomedich-767	85	2	this	this	DET
biomedich-767	85	3	study	study	NOUN
biomedich-767	85	4	,	,	PUNCT
biomedich-767	85	5	the	the	DET
biomedich-767	85	6	incremental	incremental	ADJ
biomedich-767	85	7	cost	cost	NOUN
biomedich-767	85	8	effectiveness	effectiveness	NOUN
biomedich-767	85	9	ratio	ratio	NOUN
biomedich-767	85	10	(	(	PUNCT
biomedich-767	85	11	icer	icer	NOUN
biomedich-767	85	12	)	)	PUNCT
biomedich-767	85	13	is	be	AUX
biomedich-767	85	14	not	not	PART
biomedich-767	85	15	calculated	calculate	VERB
biomedich-767	85	16	because	because	SCONJ
biomedich-767	85	17	the	the	DET
biomedich-767	85	18	results	result	NOUN
biomedich-767	85	19	of	of	ADP
biomedich-767	85	20	the	the	DET
biomedich-767	85	21	calculation	calculation	NOUN
biomedich-767	85	22	of	of	ADP
biomedich-767	85	23	cost	cost	NOUN
biomedich-767	85	24	effectiveness	effectiveness	NOUN
biomedich-767	85	25	are	be	AUX
biomedich-767	85	26	included	include	VERB
biomedich-767	85	27	in	in	ADP
biomedich-767	85	28	the	the	DET
biomedich-767	85	29	table	table	NOUN
biomedich-767	85	30	of	of	ADP
biomedich-767	85	31	areas	area	NOUN
biomedich-767	85	32	c	c	PROPN
biomedich-767	85	33	and	and	CCONJ
biomedich-767	85	34	g	g	PROPN
biomedich-767	85	35	in	in	ADP
biomedich-767	85	36	the	the	DET
biomedich-767	85	37	cost	cost	NOUN
biomedich-767	85	38	-	-	PUNCT
biomedich-767	85	39	effectiveness	effectiveness	NOUN
biomedich-767	85	40	grid	grid	NOUN
biomedich-767	85	41	(	(	PUNCT
biomedich-767	85	42	meaning	mean	VERB
biomedich-767	85	43	that	that	SCONJ
biomedich-767	85	44	area	area	NOUN
biomedich-767	85	45	g	g	NOUN
biomedich-767	85	46	shows	show	VERB
biomedich-767	85	47	dominant	dominant	ADJ
biomedich-767	85	48	results	result	NOUN
biomedich-767	85	49	and	and	CCONJ
biomedich-767	85	50	definitely	definitely	ADV
biomedich-767	85	51	does	do	AUX
biomedich-767	85	52	not	not	PART
biomedich-767	85	53	need	need	VERB
biomedich-767	85	54	to	to	PART
biomedich-767	85	55	be	be	AUX
biomedich-767	85	56	selected	select	VERB
biomedich-767	85	57	)	)	PUNCT
biomedich-767	85	58	.	.	PUNCT
biomedich-767	86	1	rieb	rieb	NOUN
biomedich-767	86	2	/	/	SYM
biomedich-767	86	3	icer	icer	NOUN
biomedich-767	86	4	.	.	PUNCT
biomedich-767	86	5	area	area	PROPN
biomedich-767	86	6	c	c	PROPN
biomedich-767	86	7	shows	show	VERB
biomedich-767	86	8	dominant	dominant	ADJ
biomedich-767	86	9	results	result	NOUN
biomedich-767	86	10	and	and	CCONJ
biomedich-767	86	11	does	do	AUX
biomedich-767	86	12	not	not	PART
biomedich-767	86	13	need	need	VERB
biomedich-767	86	14	to	to	PART
biomedich-767	86	15	be	be	AUX
biomedich-767	86	16	considered	consider	VERB
biomedich-767	86	17	as	as	ADP
biomedich-767	86	18	an	an	DET
biomedich-767	86	19	alternative	alternative	NOUN
biomedich-767	86	20	,	,	PUNCT
biomedich-767	86	21	so	so	SCONJ
biomedich-767	86	22	it	it	PRON
biomedich-767	86	23	does	do	AUX
biomedich-767	86	24	not	not	PART
biomedich-767	86	25	need	need	VERB
biomedich-767	86	26	to	to	PART
biomedich-767	86	27	be	be	AUX
biomedich-767	86	28	included	include	VERB
biomedich-767	86	29	in	in	ADP
biomedich-767	86	30	the	the	DET
biomedich-767	86	31	rieb	rieb	NOUN
biomedich-767	86	32	/	/	SYM
biomedich-767	86	33	icer	icer	NOUN
biomedich-767	86	34	calculation	calculation	NOUN
biomedich-767	86	35	.	.	PUNCT
biomedich-767	87	1	the	the	DET
biomedich-767	87	2	acer	acer	NOUN
biomedich-767	87	3	price	price	NOUN
biomedich-767	87	4	is	be	AUX
biomedich-767	87	5	obtained	obtain	VERB
biomedich-767	87	6	from	from	ADP
biomedich-767	87	7	a	a	DET
biomedich-767	87	8	comparison	comparison	NOUN
biomedich-767	87	9	between	between	ADP
biomedich-767	87	10	the	the	DET
biomedich-767	87	11	total	total	ADJ
biomedich-767	87	12	cost	cost	NOUN
biomedich-767	87	13	of	of	ADP
biomedich-767	87	14	treatment	treatment	NOUN
biomedich-767	87	15	and	and	CCONJ
biomedich-767	87	16	the	the	DET
biomedich-767	87	17	effectiveness	effectiveness	NOUN
biomedich-767	87	18	of	of	ADP
biomedich-767	87	19	therapy	therapy	NOUN
biomedich-767	87	20	.	.	PUNCT
biomedich-767	88	1	the	the	DET
biomedich-767	88	2	effectiveness	effectiveness	NOUN
biomedich-767	88	3	of	of	ADP
biomedich-767	88	4	therapy	therapy	NOUN
biomedich-767	88	5	was	be	AUX
biomedich-767	88	6	measured	measure	VERB
biomedich-767	88	7	by	by	ADP
biomedich-767	88	8	the	the	DET
biomedich-767	88	9	number	number	NOUN
biomedich-767	88	10	of	of	ADP
biomedich-767	88	11	days	day	NOUN
biomedich-767	88	12	per	per	ADP
biomedich-767	88	13	treatment	treatment	NOUN
biomedich-767	88	14	(	(	PUNCT
biomedich-767	88	15	afdal	afdal	NOUN
biomedich-767	88	16	af	af	PROPN
biomedich-767	88	17	2011	2011	NUM
biomedich-767	88	18	)	)	PUNCT
biomedich-767	88	19	.	.	PUNCT
biomedich-767	89	1	based	base	VERB
biomedich-767	89	2	on	on	ADP
biomedich-767	89	3	cost	cost	NOUN
biomedich-767	89	4	-	-	PUNCT
biomedich-767	89	5	effectiveness	effectiveness	NOUN
biomedich-767	89	6	parameters	parameter	NOUN
biomedich-767	89	7	,	,	PUNCT
biomedich-767	89	8	the	the	DET
biomedich-767	89	9	acer	acer	NOUN
biomedich-767	89	10	value	value	NOUN
biomedich-767	89	11	based	base	VERB
biomedich-767	89	12	on	on	ADP
biomedich-767	89	13	the	the	DET
biomedich-767	89	14	length	length	NOUN
biomedich-767	89	15	of	of	ADP
biomedich-767	89	16	days	day	NOUN
biomedich-767	89	17	from	from	ADP
biomedich-767	89	18	favipiravir	favipiravir	PROPN
biomedich-767	89	19	is	be	AUX
biomedich-767	89	20	rp	rp	NOUN
biomedich-767	89	21	.	.	PROPN
biomedich-767	89	22	1,521,899,195	1,521,899,195	NUM
biomedich-767	89	23	(	(	PUNCT
biomedich-767	89	24	proportion	proportion	NOUN
biomedich-767	89	25	of	of	ADP
biomedich-767	89	26	treatment	treatment	NOUN
biomedich-767	89	27	days	day	NOUN
biomedich-767	89	28	:	:	PUNCT
biomedich-767	89	29	6,525	6,525	NUM
biomedich-767	89	30	)	)	PUNCT
biomedich-767	89	31	,	,	PUNCT
biomedich-767	89	32	while	while	SCONJ
biomedich-767	89	33	oseltamivir	oseltamivir	PROPN
biomedich-767	89	34	is	be	AUX
biomedich-767	89	35	rp	rp	NOUN
biomedich-767	89	36	.	.	PUNCT
biomedich-767	89	37	1,560,681,009	1,560,681,009	NUM
biomedich-767	89	38	.	.	PUNCT
biomedich-767	90	1	in	in	ADP
biomedich-767	90	2	the	the	DET
biomedich-767	90	3	favipiravir	favipiravir	PROPN
biomedich-767	90	4	group	group	NOUN
biomedich-767	90	5	,	,	PUNCT
biomedich-767	90	6	the	the	DET
biomedich-767	90	7	acer	acer	NOUN
biomedich-767	90	8	price	price	NOUN
biomedich-767	90	9	was	be	AUX
biomedich-767	90	10	lower	low	ADJ
biomedich-767	90	11	than	than	ADP
biomedich-767	90	12	in	in	ADP
biomedich-767	90	13	the	the	DET
biomedich-767	90	14	oseltamivir	oseltamivir	PROPN
biomedich-767	90	15	group	group	NOUN
biomedich-767	90	16	.	.	PUNCT
biomedich-767	91	1	this	this	PRON
biomedich-767	91	2	suggests	suggest	VERB
biomedich-767	91	3	that	that	SCONJ
biomedich-767	91	4	favipiravir	favipiravir	PROPN
biomedich-767	91	5	therapy	therapy	NOUN
biomedich-767	91	6	is	be	AUX
biomedich-767	91	7	more	more	ADV
biomedich-767	91	8	cost	cost	NOUN
biomedich-767	91	9	-	-	PUNCT
biomedich-767	91	10	effective	effective	ADJ
biomedich-767	91	11	or	or	CCONJ
biomedich-767	91	12	has	have	VERB
biomedich-767	91	13	the	the	DET
biomedich-767	91	14	most	most	ADV
biomedich-767	91	15	cost	cost	NOUN
biomedich-767	91	16	-	-	PUNCT
biomedich-767	91	17	effectiveness	effectiveness	NOUN
biomedich-767	91	18	compared	compare	VERB
biomedich-767	91	19	with	with	ADP
biomedich-767	91	20	oseltamivir	oseltamivir	PROPN
biomedich-767	91	21	therapy	therapy	NOUN
biomedich-767	91	22	.	.	PUNCT
biomedich-767	92	1	conclusions	conclusion	NOUN
biomedich-767	92	2	based	base	VERB
biomedich-767	92	3	on	on	ADP
biomedich-767	92	4	the	the	DET
biomedich-767	92	5	results	result	NOUN
biomedich-767	92	6	of	of	ADP
biomedich-767	92	7	this	this	DET
biomedich-767	92	8	study	study	NOUN
biomedich-767	92	9	,	,	PUNCT
biomedich-767	92	10	it	it	PRON
biomedich-767	92	11	can	can	AUX
biomedich-767	92	12	be	be	AUX
biomedich-767	92	13	concluded	conclude	VERB
biomedich-767	92	14	that	that	SCONJ
biomedich-767	92	15	the	the	DET
biomedich-767	92	16	favipiravir	favipiravir	PROPN
biomedich-767	92	17	antiretroviral	antiretroviral	ADJ
biomedich-767	92	18	therapy	therapy	NOUN
biomedich-767	92	19	group	group	NOUN
biomedich-767	92	20	is	be	AUX
biomedich-767	92	21	more	more	ADV
biomedich-767	92	22	costeffective	costeffective	ADJ
biomedich-767	92	23	in	in	ADP
biomedich-767	92	24	the	the	DET
biomedich-767	92	25	treatment	treatment	NOUN
biomedich-767	92	26	of	of	ADP
biomedich-767	92	27	covid-19	covid-19	PROPN
biomedich-767	92	28	compared	compare	VERB
biomedich-767	92	29	to	to	ADP
biomedich-767	92	30	the	the	DET
biomedich-767	92	31	oseltamivir	oseltamivir	PROPN
biomedich-767	92	32	antiretroviral	antiretroviral	ADJ
biomedich-767	92	33	therapy	therapy	NOUN
biomedich-767	92	34	group	group	NOUN
biomedich-767	92	35	.	.	PUNCT
biomedich-767	93	1	acknowledgements	acknowledgement	NOUN
biomedich-767	93	2	:	:	PUNCT
biomedich-767	93	3	praise	praise	NOUN
biomedich-767	93	4	and	and	CCONJ
biomedich-767	93	5	thank	thank	VERB
biomedich-767	93	6	allah	allah	PROPN
biomedich-767	93	7	swt	swt	PROPN
biomedich-767	93	8	for	for	ADP
biomedich-767	93	9	all	all	DET
biomedich-767	93	10	his	his	PRON
biomedich-767	93	11	mercy	mercy	NOUN
biomedich-767	93	12	and	and	CCONJ
biomedich-767	93	13	pleasure	pleasure	NOUN
biomedich-767	93	14	so	so	SCONJ
biomedich-767	93	15	that	that	SCONJ
biomedich-767	93	16	the	the	DET
biomedich-767	93	17	author	author	NOUN
biomedich-767	93	18	can	can	AUX
biomedich-767	93	19	complete	complete	VERB
biomedich-767	93	20	this	this	DET
biomedich-767	93	21	writing	writing	NOUN
biomedich-767	93	22	process	process	NOUN
biomedich-767	93	23	.	.	PUNCT
biomedich-767	94	1	the	the	DET
biomedich-767	94	2	author	author	NOUN
biomedich-767	94	3	would	would	AUX
biomedich-767	94	4	like	like	VERB
biomedich-767	94	5	to	to	PART
biomedich-767	94	6	thank	thank	VERB
biomedich-767	94	7	all	all	DET
biomedich-767	94	8	parties	party	NOUN
biomedich-767	94	9	who	who	PRON
biomedich-767	94	10	have	have	AUX
biomedich-767	94	11	played	play	VERB
biomedich-767	94	12	a	a	DET
biomedich-767	94	13	role	role	NOUN
biomedich-767	94	14	in	in	ADP
biomedich-767	94	15	this	this	DET
biomedich-767	94	16	writing	writing	NOUN
biomedich-767	94	17	process	process	NOUN
biomedich-767	94	18	,	,	PUNCT
biomedich-767	94	19	especially	especially	ADV
biomedich-767	94	20	the	the	DET
biomedich-767	94	21	directorate	directorate	ADJ
biomedich-767	94	22	general	general	NOUN
biomedich-767	94	23	of	of	ADP
biomedich-767	94	24	higher	high	ADJ
biomedich-767	94	25	education	education	NOUN
biomedich-767	94	26	,	,	PUNCT
biomedich-767	94	27	research	research	NOUN
biomedich-767	94	28	,	,	PUNCT
biomedich-767	94	29	and	and	CCONJ
biomedich-767	94	30	technology	technology	NOUN
biomedich-767	94	31	of	of	ADP
biomedich-767	94	32	the	the	DET
biomedich-767	94	33	ministry	ministry	PROPN
biomedich-767	94	34	of	of	ADP
biomedich-767	94	35	education	education	PROPN
biomedich-767	94	36	,	,	PUNCT
biomedich-767	94	37	culture	culture	NOUN
biomedich-767	94	38	,	,	PUNCT
biomedich-767	94	39	research	research	NOUN
biomedich-767	94	40	,	,	PUNCT
biomedich-767	94	41	and	and	CCONJ
biomedich-767	94	42	technology	technology	NOUN
biomedich-767	94	43	who	who	PRON
biomedich-767	94	44	have	have	AUX
biomedich-767	94	45	funded	fund	VERB
biomedich-767	94	46	this	this	DET
biomedich-767	94	47	research	research	NOUN
biomedich-767	94	48	.	.	PUNCT
biomedich-767	95	1	competing	compete	VERB
biomedich-767	95	2	interests	interest	NOUN
biomedich-767	95	3	:	:	PUNCT
biomedich-767	95	4	the	the	DET
biomedich-767	95	5	authors	author	NOUN
biomedich-767	95	6	declare	declare	VERB
biomedich-767	95	7	that	that	SCONJ
biomedich-767	95	8	there	there	PRON
biomedich-767	95	9	are	be	VERB
biomedich-767	95	10	no	no	DET
biomedich-767	95	11	competing	compete	VERB
biomedich-767	95	12	interests	interest	NOUN
biomedich-767	95	13	.	.	PUNCT
biomedich-767	96	1	funding	funding	NOUN
biomedich-767	96	2	:	:	PUNCT
biomedich-767	96	3	this	this	DET
biomedich-767	96	4	research	research	NOUN
biomedich-767	96	5	received	receive	VERB
biomedich-767	96	6	funding	funding	NOUN
biomedich-767	96	7	from	from	ADP
biomedich-767	96	8	directorate	directorate	ADJ
biomedich-767	96	9	general	general	NOUN
biomedich-767	96	10	of	of	ADP
biomedich-767	96	11	higher	high	ADJ
biomedich-767	96	12	education	education	NOUN
biomedich-767	96	13	,	,	PUNCT
biomedich-767	96	14	research	research	NOUN
biomedich-767	96	15	,	,	PUNCT
biomedich-767	96	16	and	and	CCONJ
biomedich-767	96	17	technology	technology	NOUN
biomedich-767	96	18	of	of	ADP
biomedich-767	96	19	the	the	DET
biomedich-767	96	20	ministry	ministry	PROPN
biomedich-767	96	21	of	of	ADP
biomedich-767	96	22	education	education	PROPN
biomedich-767	96	23	,	,	PUNCT
biomedich-767	96	24	culture	culture	NOUN
biomedich-767	96	25	,	,	PUNCT
biomedich-767	96	26	research	research	NOUN
biomedich-767	96	27	,	,	PUNCT
biomedich-767	96	28	and	and	CCONJ
biomedich-767	96	29	technology	technology	NOUN
biomedich-767	96	30	.	.	PUNCT
biomedich-767	97	1	references	reference	NOUN
biomedich-767	97	2	afdhal	afdhal	VERB
biomedich-767	97	3	af	af	PROPN
biomedich-767	97	4	.	.	PUNCT
biomedich-767	97	5	pharmacoeconomics	pharmacoeconomic	NOUN
biomedich-767	97	6	the	the	DET
biomedich-767	97	7	latest	late	ADJ
biomedich-767	97	8	analytical	analytical	ADJ
biomedich-767	97	9	knife	knife	NOUN
biomedich-767	97	10	of	of	ADP
biomedich-767	97	11	the	the	DET
biomedich-767	97	12	pharmaceutical	pharmaceutical	ADJ
biomedich-767	97	13	world	world	NOUN
biomedich-767	97	14	.	.	PUNCT
biomedich-767	98	1	2011	2011	NUM
biomedich-767	98	2	.	.	PUNCT
biomedich-767	99	1	1–30	1–30	PROPN
biomedich-767	99	2	p.	p.	PROPN
biomedich-767	99	3	bishnu	bishnu	PROPN
biomedich-767	99	4	p.	p.	PROPN
biomedich-767	99	5	d.	d.	PROPN
biomedich-767	99	6	,	,	PUNCT
biomedich-767	99	7	nancy	nancy	PROPN
biomedich-767	99	8	k.	k.	PROPN
biomedich-767	99	9	s.	s.	PROPN
biomedich-767	99	10	,	,	PUNCT
biomedich-767	99	11	julia	julia	PROPN
biomedich-767	99	12	h.	h.	PROPN
biomedich-767	99	13	i.	i.	PROPN
biomedich-767	99	14	,	,	PUNCT
biomedich-767	99	15	deepak	deepak	PROPN
biomedich-767	99	16	a.	a.	PROPN
biomedich-767	99	17	,	,	PUNCT
biomedich-767	99	18	and	and	CCONJ
biomedich-767	100	1	preethi	preethi	ADV
biomedich-767	100	2	w.	w.	PROPN
biomedich-767	100	3	sarscov-2	sarscov-2	PROPN
biomedich-767	100	4	infection	infection	NOUN
biomedich-767	100	5	and	and	CCONJ
biomedich-767	100	6	cardiovascular	cardiovascular	ADJ
biomedich-767	100	7	disease	disease	NOUN
biomedich-767	100	8	:	:	PUNCT
biomedich-767	100	9	covid19	covid19	NOUN
biomedich-767	100	10	heart	heart	NOUN
biomedich-767	100	11	.	.	PUNCT
biomedich-767	101	1	hear	hear	VERB
biomedich-767	101	2	lung	lung	NOUN
biomedich-767	101	3	circ	circ	NOUN
biomedich-767	101	4	.	.	PUNCT
biomedich-767	102	1	2020;29(june):973–87	2020;29(june):973–87	NUM
biomedich-767	102	2	.	.	PUNCT
biomedich-767	102	3	di	di	PROPN
biomedich-767	102	4	gennaro	gennaro	PROPN
biomedich-767	102	5	f	f	PROPN
biomedich-767	102	6	,	,	PUNCT
biomedich-767	102	7	pizzol	pizzol	PROPN
biomedich-767	102	8	d	d	NOUN
biomedich-767	102	9	,	,	PUNCT
biomedich-767	102	10	marotta	marotta	PROPN
biomedich-767	102	11	c	c	PROPN
biomedich-767	102	12	,	,	PUNCT
biomedich-767	102	13	antunes	antunes	PROPN
biomedich-767	102	14	m	m	PROPN
biomedich-767	102	15	,	,	PUNCT
biomedich-767	102	16	racalbuto	racalbuto	NOUN
biomedich-767	102	17	v	v	NOUN
biomedich-767	102	18	,	,	PUNCT
biomedich-767	102	19	veronese	veronese	ADJ
biomedich-767	102	20	n	n	CCONJ
biomedich-767	102	21	,	,	PUNCT
biomedich-767	102	22	et	et	PROPN
biomedich-767	102	23	al	al	PROPN
biomedich-767	102	24	.	.	PROPN
biomedich-767	102	25	,	,	PUNCT
biomedich-767	102	26	coronavirus	coronavirus	NOUN
biomedich-767	102	27	diseases	disease	NOUN
biomedich-767	102	28	(	(	PUNCT
biomedich-767	102	29	covid-19	covid-19	PROPN
biomedich-767	102	30	):	):	PUNCT
biomedich-767	102	31	current	current	ADJ
biomedich-767	102	32	status	status	NOUN
biomedich-767	102	33	and	and	CCONJ
biomedich-767	102	34	future	future	ADJ
biomedich-767	102	35	perspectives	perspective	NOUN
biomedich-767	102	36	:	:	PUNCT
biomedich-767	102	37	a	a	DET
biomedich-767	102	38	narrative	narrative	NOUN
biomedich-767	102	39	review	review	NOUN
biomedich-767	102	40	.	.	PUNCT
biomedich-767	102	41	"	"	PUNCT
biomedich-767	103	1	int	int	PROPN
biomedich-767	103	2	j	j	PROPN
biomedich-767	103	3	environ	environ	PROPN
biomedich-767	103	4	res	re	VERB
biomedich-767	103	5	public	public	ADJ
biomedich-767	103	6	health	health	NOUN
biomedich-767	103	7	.	.	PUNCT
biomedich-767	104	1	2020;17(8	2020;17(8	NUM
biomedich-767	104	2	)	)	PUNCT
biomedich-767	104	3	.	.	PUNCT
biomedich-767	105	1	lapostolle	lapostolle	PROPN
biomedich-767	105	2	f.	f.	PROPN
biomedich-767	105	3	,	,	PUNCT
biomedich-767	105	4	schneider	schneider	PROPN
biomedich-767	105	5	e.	e.	PROPN
biomedich-767	105	6	,	,	PUNCT
biomedich-767	105	7	vianu	vianu	PROPN
biomedich-767	105	8	i.	i.	PROPN
biomedich-767	105	9	,	,	PUNCT
biomedich-767	105	10	dollet	dollet	PROPN
biomedich-767	105	11	g.	g.	PROPN
biomedich-767	105	12	,	,	PUNCT
biomedich-767	105	13	roche	roche	PROPN
biomedich-767	105	14	b.	b.	PROPN
biomedich-767	105	15	,	,	PUNCT
biomedich-767	105	16	berdah	berdah	PROPN
biomedich-767	105	17	j.	j.	PROPN
biomedich-767	105	18	,	,	PUNCT
biomedich-767	105	19	et	et	PROPN
biomedich-767	105	20	al	al	PROPN
biomedich-767	105	21	.	.	PUNCT
biomedich-767	106	1	clinical	clinical	ADJ
biomedich-767	106	2	features	feature	NOUN
biomedich-767	106	3	of	of	ADP
biomedich-767	106	4	1487	1487	NUM
biomedich-767	106	5	covid-19	covid-19	PROPN
biomedich-767	106	6	patients	patient	NOUN
biomedich-767	106	7	with	with	ADP
biomedich-767	106	8	outpatient	outpatient	NOUN
biomedich-767	106	9	management	management	NOUN
biomedich-767	106	10	in	in	ADP
biomedich-767	106	11	the	the	DET
biomedich-767	106	12	greater	great	ADJ
biomedich-767	106	13	paris	paris	PROPN
biomedich-767	106	14	area	area	NOUN
biomedich-767	106	15	:	:	PUNCT
biomedich-767	106	16	the	the	DET
biomedich-767	106	17	covidcall	covidcall	PROPN
biomedich-767	106	18	study	study	PROPN
biomedich-767	106	19	intern	intern	PROPN
biomedich-767	106	20	emerg	emerg	PROPN
biomedich-767	106	21	med	med	PROPN
biomedich-767	107	1	[	[	X
biomedich-767	107	2	internet	internet	NOUN
biomedich-767	107	3	]	]	PUNCT
biomedich-767	107	4	.	.	PUNCT
biomedich-767	108	1	2020;15(5):813–7	2020;15(5):813–7	NUM
biomedich-767	108	2	.	.	PUNCT
biomedich-767	108	3	available	available	ADJ
biomedich-767	108	4	from	from	ADP
biomedich-767	108	5	:	:	PUNCT
biomedich-767	108	6	https://doi.org/10.1007/s11739-02002379-z	https://doi.org/10.1007/s11739-02002379-z	PROPN
biomedich-767	108	7	lingeswaran	lingeswaran	ADJ
biomedich-767	108	8	m	m	PROPN
biomedich-767	108	9	,	,	PUNCT
biomedich-767	108	10	goyal	goyal	PROPN
biomedich-767	108	11	t	t	PROPN
biomedich-767	108	12	,	,	PUNCT
biomedich-767	108	13	ghosh	ghosh	PROPN
biomedich-767	108	14	r	r	PROPN
biomedich-767	108	15	,	,	PUNCT
biomedich-767	108	16	suri	suri	PROPN
biomedich-767	108	17	s	s	PROPN
biomedich-767	108	18	,	,	PUNCT
biomedich-767	108	19	mitra	mitra	PROPN
biomedich-767	108	20	p	p	PROPN
biomedich-767	108	21	,	,	PUNCT
biomedich-767	108	22	misra	misra	PROPN
biomedich-767	108	23	s	s	PART
biomedich-767	108	24	,	,	PUNCT
biomedich-767	108	25	et	et	PROPN
biomedich-767	108	26	al	al	PROPN
biomedich-767	108	27	.	.	PROPN
biomedich-767	108	28	inflammation	inflammation	NOUN
biomedich-767	108	29	,	,	PUNCT
biomedich-767	108	30	immunity	immunity	NOUN
biomedich-767	108	31	,	,	PUNCT
biomedich-767	108	32	and	and	CCONJ
biomedich-767	108	33	immunogenetics	immunogenetic	NOUN
biomedich-767	108	34	in	in	ADP
biomedich-767	108	35	covid-19	covid-19	PROPN
biomedich-767	108	36	:	:	PUNCT
biomedich-767	108	37	a	a	DET
biomedich-767	108	38	narrative	narrative	NOUN
biomedich-767	108	39	review	review	NOUN
biomedich-767	108	40	indian	indian	PROPN
biomedich-767	108	41	j	j	PROPN
biomedich-767	108	42	clin	clin	PROPN
biomedich-767	108	43	biochem	biochem	PROPN
biomedich-767	109	1	[	[	X
biomedich-767	109	2	internet	internet	NOUN
biomedich-767	109	3	]	]	PUNCT
biomedich-767	109	4	.	.	PUNCT
biomedich-767	110	1	2020;35(3):260–73	2020;35(3):260–73	X
biomedich-767	110	2	.	.	PUNCT
biomedich-767	110	3	available	available	ADJ
biomedich-767	110	4	from	from	ADP
biomedich-767	110	5	:	:	PUNCT
biomedich-767	110	6	https://doi.org/10.1007/s12291-02000897-3	https://doi.org/10.1007/s12291-02000897-3	PROPN
biomedich-767	110	7	ministry	ministry	PROPN
biomedich-767	110	8	of	of	ADP
biomedich-767	110	9	health	health	PROPN
biomedich-767	110	10	of	of	ADP
biomedich-767	110	11	the	the	DET
biomedich-767	110	12	republic	republic	NOUN
biomedich-767	110	13	of	of	ADP
biomedich-767	110	14	indonesia	indonesia	PROPN
biomedich-767	110	15	technical	technical	PROPN
biomedich-767	110	16	guidelines	guideline	NOUN
biomedich-767	110	17	for	for	ADP
biomedich-767	110	18	pharmacoeconomic	pharmacoeconomic	ADJ
biomedich-767	110	19	analysis	analysis	NOUN
biomedich-767	110	20	in	in	ADP
biomedich-767	110	21	health	health	NOUN
biomedich-767	110	22	facilities	facility	NOUN
biomedich-767	110	23	.	.	PUNCT
biomedich-767	111	1	2016	2016	NUM
biomedich-767	111	2	.	.	PUNCT
biomedich-767	112	1	1–100	1–100	NUM
biomedich-767	112	2	p.	p.	NOUN
biomedich-767	112	3	pdpi	pdpi	PROPN
biomedich-767	112	4	,	,	PUNCT
biomedich-767	112	5	perki	perki	NOUN
biomedich-767	112	6	,	,	PUNCT
biomedich-767	112	7	papdi	papdi	VERB
biomedich-767	112	8	,	,	PUNCT
biomedich-767	112	9	perdatin	perdatin	PROPN
biomedich-767	112	10	,	,	PUNCT
biomedich-767	112	11	and	and	CCONJ
biomedich-767	112	12	idai	idai	PROPN
biomedich-767	112	13	pedoman	pedoman	NOUN
biomedich-767	112	14	tatalaksana	tatalaksana	PROPN
biomedich-767	112	15	covid-19	covid-19	PROPN
biomedich-767	112	16	edisi	edisi	VERB
biomedich-767	112	17	3	3	NUM
biomedich-767	112	18	desember	desember	NOUN
biomedich-767	112	19	2020	2020	NUM
biomedich-767	113	1	[	[	X
biomedich-767	113	2	internet	internet	NOUN
biomedich-767	113	3	]	]	PUNCT
biomedich-767	113	4	.	.	PUNCT
biomedich-767	114	1	pedoman	pedoman	NOUN
biomedich-767	114	2	tatalaksana	tatalaksana	PROPN
biomedich-767	114	3	covid-19	covid-19	PROPN
biomedich-767	114	4	.	.	PROPN
biomedich-767	114	5	2020	2020	NUM
biomedich-767	114	6	.	.	PUNCT
biomedich-767	115	1	36–37	36–37	NUM
biomedich-767	115	2	p.	p.	NOUN
biomedich-767	115	3	available	available	ADJ
biomedich-767	115	4	from	from	ADP
biomedich-767	115	5	:	:	PUNCT
biomedich-767	115	6	https://www.papdi.or.id/download/9	https://www.papdi.or.id/download/9	ADJ
biomedich-767	115	7	83	83	NUM
biomedich-767	115	8	-	-	PUNCT
biomedich-767	115	9	pedomantatalaksana	pedomantatalaksana	NOUN
biomedich-767	115	10	-	-	PUNCT
biomedich-767	115	11	covid-19edisi-3	covid-19edisi-3	NUM
biomedich-767	115	12	-	-	PUNCT
biomedich-767	115	13	desember-2020	desember-2020	NOUN
biomedich-767	115	14	rees	rees	PROPN
biomedich-767	115	15	em	em	PRON
biomedich-767	115	16	,	,	PUNCT
biomedich-767	115	17	nightingale	nightingale	PROPN
biomedich-767	115	18	es	es	PROPN
biomedich-767	115	19	,	,	PUNCT
biomedich-767	115	20	jafari	jafari	PROPN
biomedich-767	115	21	y	y	PROPN
biomedich-767	115	22	,	,	PUNCT
biomedich-767	115	23	waterlow	waterlow	PROPN
biomedich-767	115	24	nr	nr	PROPN
biomedich-767	115	25	,	,	PUNCT
biomedich-767	115	26	clifford	clifford	PROPN
biomedich-767	115	27	s	s	PROPN
biomedich-767	115	28	,	,	PUNCT
biomedich-767	115	29	carl	carl	PROPN
biomedich-767	115	30	ca	ca	PROPN
biomedich-767	115	31	,	,	PUNCT
biomedich-767	115	32	et	et	PROPN
biomedich-767	115	33	al	al	PROPN
biomedich-767	115	34	.	.	PUNCT
biomedich-767	116	1	covid-19	covid-19	PROPN
biomedich-767	116	2	length	length	NOUN
biomedich-767	116	3	of	of	ADP
biomedich-767	116	4	hospital	hospital	NOUN
biomedich-767	116	5	stay	stay	NOUN
biomedich-767	116	6	:	:	PUNCT
biomedich-767	116	7	a	a	DET
biomedich-767	116	8	systematic	systematic	ADJ
biomedich-767	116	9	review	review	NOUN
biomedich-767	116	10	and	and	CCONJ
biomedich-767	116	11	data	datum	NOUN
biomedich-767	116	12	synthesis	synthesis	NOUN
biomedich-767	116	13	bmc	bmc	NOUN
biomedich-767	116	14	med	me	VERB
biomedich-767	116	15	.	.	PUNCT
biomedich-767	117	1	2020;18(1	2020;18(1	NUM
biomedich-767	117	2	)	)	PUNCT
biomedich-767	117	3	.	.	PUNCT
biomedich-767	118	1	susilo	susilo	VERB
biomedich-767	118	2	a	a	PRON
biomedich-767	118	3	,	,	PUNCT
biomedich-767	118	4	rumende	rumende	NOUN
biomedich-767	118	5	cm	cm	NOUN
biomedich-767	118	6	,	,	PUNCT
biomedich-767	118	7	pitoyo	pitoyo	NOUN
biomedich-767	118	8	cw	cw	NOUN
biomedich-767	118	9	,	,	PUNCT
biomedich-767	118	10	santoso	santoso	PROPN
biomedich-767	118	11	wd	wd	PROPN
biomedich-767	118	12	,	,	PUNCT
biomedich-767	118	13	yulianti	yulianti	PROPN
biomedich-767	118	14	m	m	PROPN
biomedich-767	118	15	,	,	PUNCT
biomedich-767	118	16	herikurniawan	herikurniawan	ADJ
biomedich-767	118	17	h	h	NOUN
biomedich-767	118	18	,	,	PUNCT
biomedich-767	118	19	et	et	PROPN
biomedich-767	118	20	al	al	PROPN
biomedich-767	118	21	.	.	PROPN
biomedich-767	118	22	coronavirus	coronavirus	PROPN
biomedich-767	118	23	disease	disease	NOUN
biomedich-767	118	24	2019	2019	NUM
biomedich-767	118	25	:	:	PUNCT
biomedich-767	118	26	tinjauan	tinjauan	PROPN
biomedich-767	118	27	literatur	literatur	PROPN
biomedich-767	118	28	terkini	terkini	PROPN
biomedich-767	118	29	j	j	PROPN
biomedich-767	118	30	penyakit	penyakit	PROPN
biomedich-767	118	31	dalam	dalam	PROPN
biomedich-767	118	32	indones	indone	NOUN
biomedich-767	118	33	.	.	PUNCT
biomedich-767	119	1	2020;7(1):45	2020;7(1):45	NUM
biomedich-767	119	2	.	.	X
biomedich-767	119	3	suresh	suresh	PROPN
biomedich-767	119	4	kumar	kumar	PROPN
biomedich-767	119	5	vc	vc	PROPN
biomedich-767	119	6	,	,	PUNCT
biomedich-767	119	7	mukherjee	mukherjee	PROPN
biomedich-767	119	8	s	s	PROPN
biomedich-767	119	9	,	,	PUNCT
biomedich-767	119	10	harne	harne	PROPN
biomedich-767	119	11	ps	ps	PROPN
biomedich-767	119	12	,	,	PUNCT
biomedich-767	119	13	subedi	subedi	PROPN
biomedich-767	119	14	a	a	PROPN
biomedich-767	119	15	,	,	PUNCT
biomedich-767	119	16	ganapathy	ganapathy	PROPN
biomedich-767	119	17	mk	mk	PROPN
biomedich-767	119	18	,	,	PUNCT
biomedich-767	119	19	patthipati	patthipati	NOUN
biomedich-767	119	20	vs	vs	ADP
biomedich-767	119	21	,	,	PUNCT
biomedich-767	119	22	et	et	PROPN
biomedich-767	119	23	al	al	PROPN
biomedich-767	119	24	.	.	PUNCT
biomedich-767	119	25	novelty	novelty	NOUN
biomedich-767	119	26	in	in	ADP
biomedich-767	119	27	the	the	DET
biomedich-767	119	28	gut	gut	NOUN
biomedich-767	119	29	:	:	PUNCT
biomedich-767	119	30	a	a	DET
biomedich-767	119	31	systematic	systematic	ADJ
biomedich-767	119	32	review	review	NOUN
biomedich-767	119	33	and	and	CCONJ
biomedich-767	119	34	metaanalysis	metaanalysis	NOUN
biomedich-767	119	35	of	of	ADP
biomedich-767	119	36	the	the	DET
biomedich-767	119	37	gastrointestinal	gastrointestinal	ADJ
biomedich-767	119	38	manifestations	manifestation	NOUN
biomedich-767	119	39	of	of	ADP
biomedich-767	119	40	covid-19	covid-19	PROPN
biomedich-767	119	41	.	.	PUNCT
biomedich-767	119	42	bmj	bmj	PROPN
biomedich-767	119	43	open	open	ADJ
biomedich-767	119	44	gastroenterol	gastroenterol	NOUN
biomedich-767	119	45	.	.	PUNCT
biomedich-767	120	1	2020;7(1	2020;7(1	X
biomedich-767	120	2	)	)	PUNCT
biomedich-767	120	3	.	.	PUNCT
biomedich-767	121	1	song	song	PROPN
biomedich-767	121	2	y	y	PROPN
biomedich-767	121	3	,	,	PUNCT
biomedich-767	121	4	zhang	zhang	PROPN
biomedich-767	121	5	m	m	PROPN
biomedich-767	121	6	,	,	PUNCT
biomedich-767	121	7	yin	yin	PROPN
biomedich-767	121	8	l	l	PROPN
biomedich-767	121	9	,	,	PUNCT
biomedich-767	121	10	wang	wang	PROPN
biomedich-767	121	11	k	k	PROPN
biomedich-767	121	12	,	,	PUNCT
biomedich-767	121	13	zhou	zhou	PROPN
biomedich-767	121	14	y	y	PROPN
biomedich-767	121	15	,	,	PUNCT
biomedich-767	121	16	zhou	zhou	PROPN
biomedich-767	121	17	m	m	PROPN
biomedich-767	121	18	,	,	PUNCT
biomedich-767	121	19	et	et	PROPN
biomedich-767	121	20	al	al	PROPN
biomedich-767	121	21	.	.	PROPN
biomedich-767	122	1	since	since	SCONJ
biomedich-767	122	2	january	january	PROPN
biomedich-767	122	3	2020	2020	NUM
biomedich-767	122	4	,	,	PUNCT
biomedich-767	122	5	elsevier	elsevier	PROPN
biomedich-767	122	6	has	have	AUX
biomedich-767	122	7	created	create	VERB
biomedich-767	122	8	a	a	DET
biomedich-767	122	9	covid-19	covid-19	PROPN
biomedich-767	122	10	resource	resource	NOUN
biomedich-767	122	11	center	center	NOUN
biomedich-767	122	12	with	with	ADP
biomedich-767	122	13	free	free	ADJ
biomedich-767	122	14	information	information	NOUN
biomedich-767	122	15	in	in	ADP
biomedich-767	122	16	english	english	PROPN
biomedich-767	122	17	and	and	CCONJ
biomedich-767	122	18	mandarin	mandarin	NOUN
biomedich-767	122	19	on	on	ADP
biomedich-767	122	20	the	the	DET
biomedich-767	122	21	novel	novel	ADJ
biomedich-767	122	22	coronavirus	coronavirus	NOUN
biomedich-767	122	23	covid-19	covid-19	PROPN
biomedich-767	122	24	.	.	PUNCT
biomedich-767	123	1	the	the	DET
biomedich-767	123	2	covid-19	covid-19	PROPN
biomedich-767	123	3	resource	resource	NOUN
biomedich-767	123	4	center	center	NOUN
biomedich-767	123	5	is	be	AUX
biomedich-767	123	6	hosted	host	VERB
biomedich-767	123	7	on	on	ADP
biomedich-767	123	8	elsevier	elsevier	PROPN
biomedich-767	123	9	connect	connect	PROPN
biomedich-767	123	10	,	,	PUNCT
biomedich-767	123	11	the	the	DET
biomedich-767	123	12	company	company	NOUN
biomedich-767	123	13	's	's	PART
biomedich-767	123	14	public	public	ADJ
biomedich-767	123	15	news	news	NOUN
biomedich-767	123	16	and	and	CCONJ
biomedich-767	123	17	information	information	NOUN
biomedich-767	123	18	site	site	NOUN
biomedich-767	123	19	.	.	PUNCT
biomedich-767	124	1	int	int	PROPN
biomedich-767	124	2	j	j	PROPN
biomedich-767	124	3	antimicrob	antimicrob	PROPN
biomedich-767	124	4	agents	agent	NOUN
biomedich-767	125	1	[	[	X
biomedich-767	125	2	internet	internet	NOUN
biomedich-767	125	3	]	]	PUNCT
biomedich-767	125	4	.	.	PUNCT
biomedich-767	126	1	2020;56(january):1–9	2020;56(january):1–9	NUM
biomedich-767	126	2	.	.	PUNCT
biomedich-767	126	3	available	available	ADJ
biomedich-767	126	4	from	from	ADP
biomedich-767	126	5	:	:	PUNCT
biomedich-767	126	6	https://doi.org/10.1007/s12291-020-%2000897-3	https://doi.org/10.1007/s12291-020-%2000897-3	PROPN
biomedich-767	126	7	https://www.papdi.or.id/download/9%2083-pedoman-tatalaksana-covid-19-%20edisi-3-desember-2020	https://www.papdi.or.id/download/9%2083-pedoman-tatalaksana-covid-19-%20edisi-3-desember-2020	PROPN
biomedich-767	126	8	https://www.papdi.or.id/download/9%2083-pedoman-tatalaksana-covid-19-%20edisi-3-desember-2020	https://www.papdi.or.id/download/9%2083-pedoman-tatalaksana-covid-19-%20edisi-3-desember-2020	PROPN
biomedich-767	126	9	rahayu	rahayu	PROPN
biomedich-767	126	10	et	et	PROPN
biomedich-767	126	11	al	al	PROPN
biomedich-767	126	12	.	.	PROPN
biomedich-767	126	13	–	–	PUNCT
biomedich-767	126	14	cost	cost	NOUN
biomedich-767	126	15	effectiveness	effectiveness	NOUN
biomedich-767	126	16	analysis	analysis	NOUN
biomedich-767	126	17	of	of	ADP
biomedich-767	126	18	favipiravir	favipiravir	NOUN
biomedich-767	126	19	and	and	CCONJ
biomedich-767	126	20	oseltamivir	oseltamivir	NOUN
biomedich-767	126	21	as	as	ADP
biomedich-767	126	22	…	…	PUNCT
biomedich-767	126	23	1223	1223	NUM
biomedich-767	126	24	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan	ADJ
biomedich-767	126	25	olahraga	olahraga	NOUN
biomedich-767	126	26	/	/	SYM
biomedich-767	126	27	article	article	NOUN
biomedich-767	126	28	/	/	SYM
biomedich-767	126	29	view/34491	view/34491	PROPN
biomedich-767	126	30	uyeki	uyeki	PROPN
biomedich-767	126	31	tm	tm	PROPN
biomedich-767	126	32	.	.	PROPN
biomedich-767	127	1	oseltamivir	oseltamivir	PROPN
biomedich-767	127	2	treatment	treatment	NOUN
biomedich-767	127	3	of	of	ADP
biomedich-767	127	4	influenza	influenza	NOUN
biomedich-767	127	5	in	in	ADP
biomedich-767	127	6	children	child	NOUN
biomedich-767	127	7	.	.	PUNCT
biomedich-767	128	1	clin	clin	PROPN
biomedich-767	128	2	infect	infect	PROPN
biomedich-767	128	3	dis	dis	PROPN
biomedich-767	128	4	.	.	PUNCT
biomedich-767	129	1	2018;66(10):1501–3	2018;66(10):1501–3	X
biomedich-767	129	2	.	.	PUNCT
biomedich-767	130	1	ye	ye	PRON
biomedich-767	130	2	q	q	PROPN
biomedich-767	130	3	,	,	PUNCT
biomedich-767	130	4	wang	wang	PROPN
biomedich-767	130	5	b	b	PROPN
biomedich-767	130	6	mj	mj	PROPN
biomedich-767	130	7	since	since	SCONJ
biomedich-767	130	8	january	january	PROPN
biomedich-767	130	9	2020	2020	NUM
biomedich-767	130	10	,	,	PUNCT
biomedich-767	130	11	elsevier	elsevier	PROPN
biomedich-767	130	12	has	have	AUX
biomedich-767	130	13	created	create	VERB
biomedich-767	130	14	a	a	DET
biomedich-767	130	15	covid-19	covid-19	PROPN
biomedich-767	130	16	resource	resource	NOUN
biomedich-767	130	17	center	center	NOUN
biomedich-767	130	18	with	with	ADP
biomedich-767	130	19	free	free	ADJ
biomedich-767	130	20	information	information	NOUN
biomedich-767	130	21	in	in	ADP
biomedich-767	130	22	english	english	PROPN
biomedich-767	130	23	and	and	CCONJ
biomedich-767	130	24	mandarin	mandarin	NOUN
biomedich-767	130	25	on	on	ADP
biomedich-767	130	26	the	the	DET
biomedich-767	130	27	novel	novel	ADJ
biomedich-767	130	28	coronavirus	coronavirus	NOUN
biomedich-767	130	29	covid-19	covid-19	PROPN
biomedich-767	130	30	.	.	PUNCT
biomedich-767	131	1	the	the	DET
biomedich-767	131	2	covid-19	covid-19	PROPN
biomedich-767	131	3	resource	resource	NOUN
biomedich-767	131	4	center	center	NOUN
biomedich-767	131	5	is	be	AUX
biomedich-767	131	6	hosted	host	VERB
biomedich-767	131	7	on	on	ADP
biomedich-767	131	8	elsevier	elsevier	PROPN
biomedich-767	131	9	connect	connect	PROPN
biomedich-767	131	10	,	,	PUNCT
biomedich-767	131	11	the	the	DET
biomedich-767	131	12	company	company	NOUN
biomedich-767	131	13	's	's	PART
biomedich-767	131	14	public	public	ADJ
biomedich-767	131	15	news	news	NOUN
biomedich-767	131	16	and	and	CCONJ
biomedich-767	131	17	information	information	NOUN
biomedich-767	131	18	site	site	NOUN
biomedich-767	131	19	.	.	PUNCT
biomedich-767	132	1	elsevier	elsevier	NOUN
biomedich-767	132	2	.	.	PUNCT
biomedich-767	133	1	2020	2020	NUM
biomedich-767	133	2	;	;	PUNCT
biomedich-767	133	3	j	j	PROPN
biomedich-767	133	4	infect	infect	VERB
biomedich-767	133	5	.	.	PUNCT
biomedich-767	134	1	y	y	PROPN
biomedich-767	134	2	furuta	furuta	PROPN
biomedich-767	134	3	,	,	PUNCT
biomedich-767	134	4	t	t	PROPN
biomedich-767	134	5	komeno	komeno	PROPN
biomedich-767	134	6	,	,	PUNCT
biomedich-767	134	7	tn	tn	NOUN
biomedich-767	134	8	polymerase	polymerase	NOUN
biomedich-767	134	9	activity	activity	NOUN
biomedich-767	134	10	(	(	PUNCT
biomedich-767	134	11	%	%	INTJ
biomedich-767	134	12	):	):	PUNCT
biomedich-767	134	13	100	100	NUM
biomedich-767	134	14	µ	µ	PRON
biomedich-767	134	15	mol	mol	PROPN
biomedich-767	134	16	/	/	SYM
biomedich-767	134	17	ll	ll	NOUN
biomedich-767	134	18	favipiravir	favipiravir	PROPN
biomedich-767	134	19	-	-	PUNCT
biomedich-767	134	20	rmp	rmp	PROPN
biomedich-767	134	21	control	control	PROPN
biomedich-767	134	22	.	.	PUNCT
biomedich-767	135	1	proc	proc	PROPN
biomedich-767	135	2	jpn	jpn	PROPN
biomedich-767	135	3	acad	acad	PROPN
biomedich-767	135	4	ser	ser	PROPN
biomedich-767	135	5	b	b	PROPN
biomedich-767	135	6	phys	phy	NOUN
biomedich-767	135	7	biol	biol	PROPN
biomedich-767	135	8	sci	sci	PROPN
biomedich-767	136	1	[	[	X
biomedich-767	136	2	internet	internet	NOUN
biomedich-767	136	3	]	]	PUNCT
biomedich-767	136	4	.	.	PUNCT
biomedich-767	137	1	2017;93(7):449–63	2017;93(7):449–63	NUM
biomedich-767	137	2	.	.	NOUN
biomedich-767	137	3	available	available	ADJ
biomedich-767	137	4	from	from	ADP
biomedich-767	137	5	:	:	PUNCT
biomedich-767	137	6	https://www.ncbi.nlm.nih.gov/pmc/a	https://www.ncbi.nlm.nih.gov/pmc/a	NUM
biomedich-767	137	7	rticles	rticle	NOUN
biomedich-767	137	8	/	/	SYM
biomedich-767	137	9	pmc5713175	pmc5713175	NOUN
biomedich-767	137	10	/	/	SYM
biomedich-767	137	11	pdf	pdf	NOUN
biomedich-767	137	12	/	/	SYM
biomedich-767	137	13	pjab-93449	pjab-93449	NOUN
biomedich-767	137	14	zhu	zhu	PROPN
biomedich-767	137	15	n	n	CCONJ
biomedich-767	137	16	,	,	PUNCT
biomedich-767	137	17	zhang	zhang	PROPN
biomedich-767	137	18	d	d	PROPN
biomedich-767	137	19	,	,	PUNCT
biomedich-767	137	20	wang	wang	PROPN
biomedich-767	137	21	w	w	PROPN
biomedich-767	137	22	,	,	PUNCT
biomedich-767	137	23	li	li	PROPN
biomedich-767	137	24	x	x	PROPN
biomedich-767	137	25	,	,	PUNCT
biomedich-767	137	26	yang	yang	PROPN
biomedich-767	137	27	b	b	PROPN
biomedich-767	137	28	,	,	PUNCT
biomedich-767	137	29	song	song	PROPN
biomedich-767	137	30	j	j	PROPN
biomedich-767	137	31	,	,	PUNCT
biomedich-767	137	32	et	et	PROPN
biomedich-767	137	33	al	al	PROPN
biomedich-767	137	34	.	.	PROPN
biomedich-767	137	35	,	,	PUNCT
biomedich-767	137	36	a	a	DET
biomedich-767	137	37	novel	novel	ADJ
biomedich-767	137	38	coronavirus	coronavirus	NOUN
biomedich-767	137	39	from	from	ADP
biomedich-767	137	40	patients	patient	NOUN
biomedich-767	137	41	with	with	ADP
biomedich-767	137	42	pneumonia	pneumonia	NOUN
biomedich-767	137	43	in	in	ADP
biomedich-767	137	44	china	china	PROPN
biomedich-767	137	45	,	,	PUNCT
biomedich-767	137	46	2019	2019	NUM
biomedich-767	137	47	.	.	PUNCT
biomedich-767	138	1	n	n	X
biomedich-767	138	2	engl	engl	PROPN
biomedich-767	138	3	j	j	PROPN
biomedich-767	138	4	med	med	PROPN
biomedich-767	138	5	.	.	PUNCT
biomedich-767	139	1	2020;382(8):727–33	2020;382(8):727–33	PROPN
biomedich-767	139	2	.	.	PUNCT
biomedich-767	140	1	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan-%20olahraga/article/view/34491	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan-%20olahraga/article/view/34491	PROPN
biomedich-767	140	2	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan-%20olahraga/article/view/34491	https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan-%20olahraga/article/view/34491	PROPN
biomedich-767	141	1	https://www.ncbi.nlm.nih.gov/pmc/a%20rticles/pmc5713175/pdf/pjab-93-%20449	https://www.ncbi.nlm.nih.gov/pmc/a%20rticles/pmc5713175/pdf/pjab-93-%20449	PROPN
biomedich-767	141	2	https://www.ncbi.nlm.nih.gov/pmc/a%20rticles/pmc5713175/pdf/pjab-93-%20449	https://www.ncbi.nlm.nih.gov/pmc/a%20rticles/pmc5713175/pdf/pjab-93-%20449	PRON
biomedich-767	141	3	this	this	DET
biomedich-767	141	4	page	page	NOUN
biomedich-767	141	5	intentionally	intentionally	ADV
biomedich-767	141	6	left	leave	VERB
biomedich-767	141	7	blank	blank	ADV